Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",A1BG,Alpha-1B-glycoprotein,18511,1612,1.96 [1.45-2.64],1.0418045457706468e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AARSD1,Alanyl-tRNA editing protein Aarsd1,21186,1853,1.08 [1.00-1.16],0.0400664506023811
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,17856,1551,1.18 [1.02-1.36],0.0246284528707163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABL1,Tyrosine-protein kinase ABL1,21186,1853,1.08 [1.02-1.15],0.0084089706325302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",20784,1814,1.20 [1.14-1.26],3.123962945323044e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE,Angiotensin-converting enzyme,18509,1603,1.26 [1.05-1.52],0.0124491469701007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,20906,1832,1.33 [1.23-1.43],2.3147430135304766e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,21289,1860,1.11 [1.02-1.20],0.010982891305069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,17944,1562,0.80 [0.72-0.90],8.867565893395803e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,21379,1864,1.48 [1.32-1.67],9.076164777272904e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,21448,1875,1.09 [1.02-1.16],0.0107290908357545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTA2,"Actin, aortic smooth muscle",20906,1832,1.21 [1.11-1.32],1.0076542569705308e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN4,Alpha-actinin-4,20914,1833,1.18 [1.04-1.35],0.0092909232138831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,21064,1844,2.02 [1.75-2.34],2.3684819650275854e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,21289,1860,1.24 [1.16-1.32],3.1558216846024776e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,17856,1551,1.15 [1.06-1.25],0.0011866074820154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA,Adenosine deaminase,21543,1879,1.17 [1.05-1.30],0.0030681503982873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA2,Adenosine deaminase 2,21179,1847,1.24 [1.13-1.37],1.1379649306487164e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,17944,1562,1.53 [1.34-1.73],5.1658756748244426e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,20906,1832,1.20 [1.05-1.37],0.0067961374085623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,21104,1848,0.76 [0.69-0.85],1.1639210582921003e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,21450,1874,1.39 [1.21-1.60],2.466053094854432e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,18435,1602,1.45 [1.23-1.70],8.406358599984638e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,17944,1562,1.17 [1.00-1.36],0.049629827541195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,21556,1882,0.68 [0.57-0.80],7.467223832690105e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,21186,1853,1.25 [1.13-1.38],2.262159746094844e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,17944,1562,1.31 [1.16-1.48],2.4819241937815618e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,21352,1860,0.81 [0.74-0.89],6.4680187617462135e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,18498,1605,1.90 [1.68-2.15],4.01972361637824e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,17992,1559,1.52 [1.24-1.87],6.35088998570289e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,20784,1814,0.87 [0.76-0.99],0.0397652343379473
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,18077,1558,1.62 [1.46-1.79],6.888290629731606e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,21367,1868,0.84 [0.73-0.97],0.0163715502379725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,21451,1873,0.82 [0.72-0.94],0.0042351212727878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRF5,Adhesion G protein-coupled receptor F5,18494,1603,1.21 [1.02-1.43],0.0282919297998953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,21186,1853,1.10 [1.04-1.15],0.0002809355727989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,20906,1832,1.06 [1.01-1.12],0.0233375207391014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADIPOQ,Adiponectin,18511,1612,1.21 [1.13-1.29],6.950448691520471e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,21472,1876,2.73 [2.32-3.20],3.138194425393302e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,21236,1857,0.84 [0.76-0.92],0.0004371736087263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,20683,1820,1.13 [1.09-1.18],9.150078293132504e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR3,Anterior gradient protein 3,20754,1812,1.07 [1.00-1.15],0.0494535924538038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,21367,1868,1.43 [1.27-1.60],2.072431438897286e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRP,Agouti-related protein,21543,1879,1.09 [1.01-1.18],0.0293492005387904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,21289,1860,1.16 [1.10-1.23],2.60335210329976e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,17992,1559,1.24 [1.08-1.41],0.0020037217618496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1,Allograft inflammatory factor 1,20784,1814,1.10 [1.02-1.19],0.0139911073125294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",21155,1849,1.09 [1.04-1.13],2.509615008677192e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,18001,1566,1.15 [1.07-1.24],0.0001197476669619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,20906,1832,1.14 [1.07-1.23],0.0001978371547728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR7L,Aflatoxin B1 aldehyde reductase member 4,17944,1562,1.11 [1.04-1.19],0.0034076363171822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALCAM,CD166 antigen,21556,1882,1.33 [1.08-1.65],0.0075272998278799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH1A1,Retinal dehydrogenase 1,21302,1865,1.15 [1.07-1.24],0.0001458828423168
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",21245,1861,1.18 [1.12-1.25],2.7679149799066527e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",18454,1594,1.29 [1.17-1.43],2.410095846971856e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",21186,1853,1.22 [1.17-1.27],3.299437490661569e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,21442,1872,1.66 [1.37-2.02],4.240980227603286e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMFR,E3 ubiquitin-protein ligase AMFR,20838,1837,1.07 [1.00-1.14],0.0403911244144755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO2,Amphoterin-induced protein 2,21186,1853,1.36 [1.14-1.62],0.0005991148145681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOT,Angiomotin,18077,1558,0.73 [0.64-0.83],2.075559224832605e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2A,Pancreatic alpha-amylase,20503,1784,0.92 [0.84-1.00],0.0449232247163498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2B,Alpha-amylase 2B,19850,1721,0.91 [0.84-0.99],0.0362967606509343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,21250,1853,1.43 [1.27-1.62],7.40823613036622e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,21472,1876,1.71 [1.54-1.91],3.6876927756135547e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,20960,1825,1.42 [1.22-1.64],3.453100898271698e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL2,Angiopoietin-related protein 2,21291,1861,1.13 [1.02-1.25],0.0160806717513277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,21325,1860,1.26 [1.12-1.43],0.0001524043368311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,21336,1865,1.45 [1.33-1.59],2.840948787874009e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,21472,1876,1.34 [1.21-1.48],2.6255073334855685e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANPEP,Aminopeptidase N,21362,1861,1.57 [1.33-1.84],3.668369216129272e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,20838,1837,1.14 [1.08-1.20],4.801988668485044e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA2,Annexin A2,17730,1541,1.12 [1.06-1.20],0.0002144561415695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA3,Annexin A3,21450,1874,1.06 [1.00-1.13],0.0364631838582505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC3,Membrane primary amine oxidase,21393,1864,1.55 [1.35-1.79],1.6901454097263114e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP1G2,AP-1 complex subunit gamma-like 2,18419,1587,1.08 [1.02-1.15],0.006189967029171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APCS,Serum amyloid P-component,18354,1597,1.32 [1.13-1.54],0.0004310633379914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,21415,1872,1.13 [1.05-1.20],0.0006142883070437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,21289,1860,0.78 [0.72-0.85],3.4291348850627316e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA1,Apolipoprotein A-I,18511,1612,1.20 [1.02-1.42],0.0301178395335636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA2,Apolipoprotein A-II,18509,1603,1.18 [1.07-1.30],0.0005552100063616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOC1,Apolipoprotein C-I,18483,1611,1.22 [1.09-1.37],0.0008352108410527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOD,Apolipoprotein D,17704,1531,1.13 [1.00-1.26],0.0468595261245039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOE,Apolipoprotein E,18511,1612,1.07 [1.00-1.14],0.0367821138645098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOM,Apolipoprotein M,21360,1861,1.19 [1.03-1.38],0.015357483224906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APP,Amyloid-beta precursor protein,21268,1861,1.08 [1.01-1.15],0.0147572460434684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,21186,1853,1.82 [1.65-2.00],4.6530930152885755e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP30,Rho GTPase-activating protein 30,18165,1571,0.83 [0.70-0.97],0.0228955708154234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF5,Rho guanine nucleotide exchange factor 5,17877,1545,1.10 [1.03-1.18],0.0055398326569989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL13B,ADP-ribosylation factor-like protein 13B,17856,1551,1.10 [1.03-1.18],0.0046388116623049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSA,Arylsulfatase A,21302,1865,1.17 [1.07-1.27],0.0005856685054888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSB,Arylsulfatase B,21186,1853,1.11 [1.03-1.19],0.0064805224955931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,21393,1864,0.85 [0.76-0.95],0.0057556615372216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH1,Acid ceramidase,18331,1596,1.22 [1.10-1.35],0.0001942418136137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH2,Neutral ceramidase,21104,1848,0.92 [0.86-0.99],0.0268344873815003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,21104,1848,1.83 [1.63-2.05],1.34401330292528e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,18509,1603,1.91 [1.59-2.29],4.2801122262928135e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATG16L1,Autophagy-related protein 16-1,18435,1602,1.06 [1.00-1.12],0.0367438916662185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATOX1,Copper transport protein ATOX1,21352,1860,1.08 [1.02-1.15],0.0060369340022106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,18435,1602,1.32 [1.14-1.53],0.00024148757636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,21393,1864,0.78 [0.67-0.91],0.0018034064088516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZI2,5-azacytidine-induced protein 2,18454,1594,1.11 [1.02-1.21],0.0142022304015987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZU1,Azurocidin,20674,1799,1.11 [1.05-1.16],4.233192025043754e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,18511,1612,1.50 [1.36-1.65],6.87375878651356e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",17992,1559,1.36 [1.19-1.55],4.221196329673823e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",21367,1868,1.40 [1.21-1.61],4.255145335272606e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,20784,1814,1.24 [1.16-1.32],1.8070495920122048e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,20784,1814,1.24 [1.06-1.44],0.0055909164034606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAP18,Chromatin complexes subunit BAP18,18446,1599,1.12 [1.05-1.19],0.000468880085616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAX,Apoptosis regulator BAX,20803,1831,1.06 [1.01-1.11],0.0093840240282395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAM,Basal cell adhesion molecule,21302,1865,1.35 [1.14-1.61],0.0004672522392195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,21104,1848,0.60 [0.53-0.67],5.8269219093180464e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",18494,1603,1.27 [1.09-1.47],0.0016824992021509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2,Apoptosis regulator Bcl-2,18435,1602,1.11 [1.02-1.21],0.0136773558321582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",21282,1863,1.21 [1.09-1.34],0.0003264396560607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L15,Bcl-2-like protein 15,17944,1562,1.09 [1.01-1.18],0.0244533971256022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BDNF,Brain-derived neurotrophic factor,18498,1605,1.08 [1.02-1.15],0.007320179275827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGN,Biglycan,20754,1810,0.96 [0.93-1.00],0.0291201227933771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,18077,1558,1.75 [1.41-2.19],5.343664129017388e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,17944,1562,1.25 [1.12-1.39],3.849624232986798e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,21257,1855,1.45 [1.36-1.54],3.2972043871775215e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRK1,Protein BRICK1,20838,1837,1.13 [1.03-1.24],0.0075825270686276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,21507,1876,2.35 [1.94-2.85],4.141774820888349e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,21484,1876,1.54 [1.44-1.65],1.977130926780645e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTC,Probetacellulin,20784,1814,1.09 [1.03-1.15],0.001510623166988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,21367,1868,1.36 [1.17-1.59],7.512241956470324e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,21282,1863,1.30 [1.17-1.44],1.2810899006875658e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C19orf12,Protein C19orf12,20838,1837,1.15 [1.09-1.22],1.2108982999373887e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QL2,Complement C1q-like protein 2,17944,1562,1.18 [1.06-1.31],0.0022312071639786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,21393,1864,1.32 [1.20-1.45],3.346860836105882e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,18048,1555,0.84 [0.77-0.93],0.0004474150634515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1R,Complement C1r subcomponent,18511,1612,1.54 [1.17-2.02],0.001777559016183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1S,Complement C1s subcomponent,18511,1612,1.46 [1.16-1.83],0.0013223071465897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2,Complement C2,21360,1861,1.34 [1.09-1.65],0.0052372772904458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2CD2L,Phospholipid transfer protein C2CD2L,20809,1835,1.21 [1.09-1.34],0.0002557125042082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C3,Complement C3,17604,1535,1.18 [1.07-1.31],0.0016482145709156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C4BPB,C4b-binding protein beta chain,21352,1860,0.90 [0.81-0.99],0.0387137873077241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C5,Complement C5,18511,1612,1.44 [1.06-1.94],0.0187294970407278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,18066,1572,1.73 [1.49-2.01],1.1746575573131314e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7orf50,Uncharacterized protein C7orf50,18446,1599,1.26 [1.06-1.49],0.0083632857322352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C8B,Complement component C8 beta chain,18511,1612,1.26 [1.07-1.47],0.0045892678492339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA12,Carbonic anhydrase 12,21186,1853,1.17 [1.03-1.32],0.0170918476992704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,21472,1876,0.73 [0.65-0.82],1.9789576215275853e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,21556,1882,1.56 [1.33-1.83],7.191385787843766e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",20906,1832,1.13 [1.08-1.18],3.542801931835192e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,21237,1860,0.80 [0.75-0.86],8.507789528294004e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA8,Carbonic anhydrase-related protein,17944,1562,0.78 [0.63-0.98],0.034675528050305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA9,Carbonic anhydrase 9,21472,1876,1.23 [1.12-1.35],8.155378398979193e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,21075,1846,1.12 [1.06-1.19],0.0001016143287439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCB,Calcitonin gene-related peptide 2,18446,1599,1.29 [1.14-1.46],5.29457162160305e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,20784,1814,1.10 [1.01-1.21],0.0379127496899744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,18454,1594,1.06 [1.01-1.11],0.0122613125257436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,21219,1849,1.38 [1.13-1.68],0.001844176213033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,21139,1848,1.21 [1.13-1.29],8.321952774160932e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP1,Caspase-1,20838,1837,1.06 [1.01-1.13],0.0276309298267038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,21260,1858,1.07 [1.01-1.13],0.0264905199900128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,21472,1876,0.72 [0.63-0.81],2.9326122749190694e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBS,Cystathionine beta-synthase,17992,1559,1.14 [1.04-1.25],0.0040727332893243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCAR2,Cell cycle and apoptosis regulator protein 2,18446,1599,1.11 [1.03-1.20],0.0043234958658642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,21289,1860,1.53 [1.36-1.72],1.2490322628452688e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,17992,1559,0.86 [0.79-0.93],0.0001674814995169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL11,Eotaxin,21543,1879,1.30 [1.17-1.45],2.029251739360424e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL14,C-C motif chemokine 14,21250,1853,1.22 [1.11-1.34],5.784144901393654e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,21556,1882,1.31 [1.20-1.43],1.518733798122927e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,21556,1882,1.23 [1.13-1.34],6.03087775610622e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,21218,1857,1.14 [1.09-1.18],4.378527449682512e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL18,C-C motif chemokine 18,21021,1836,1.13 [1.07-1.19],1.370629231624197e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL19,C-C motif chemokine 19,21484,1876,1.08 [1.05-1.11],1.6431450216605082e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,21543,1879,1.22 [1.17-1.28],6.390314245826694e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,21367,1868,1.51 [1.40-1.62],4.950218137326337e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,21047,1838,1.37 [1.27-1.48],9.791018864175656e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL23,C-C motif chemokine 23,21367,1868,1.26 [1.15-1.39],2.225322946250424e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL25,C-C motif chemokine 25,21543,1879,1.22 [1.12-1.32],1.5045016956453951e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL27,C-C motif chemokine 27,21289,1860,1.17 [1.10-1.25],3.10074680947737e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,21214,1855,1.19 [1.12-1.27],2.2532811876481163e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL3,C-C motif chemokine 3,21282,1863,1.15 [1.09-1.20],9.518370925643845e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL5,C-C motif chemokine 5,21393,1864,1.09 [1.05-1.14],1.884146434255438e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,21282,1863,1.24 [1.17-1.32],4.286473146922877e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL8,C-C motif chemokine 8,21442,1872,1.08 [1.01-1.15],0.0191842498258189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN1,CCN family member 1,21156,1849,1.13 [1.07-1.19],2.70998473957162e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN2,CCN family member 2,21266,1861,1.09 [1.02-1.17],0.0159932231403221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,21515,1875,1.30 [1.15-1.48],2.7686114454956108e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN4,CCN family member 4,21472,1876,1.27 [1.14-1.41],9.89938742742748e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD101,Immunoglobulin superfamily member 2,18435,1602,1.29 [1.14-1.45],2.44388288247504e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,20900,1824,1.61 [1.46-1.78],4.239575839073812e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,21393,1864,1.33 [1.22-1.46],3.3524095118553357e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD177,CD177 antigen,21269,1862,1.05 [1.01-1.08],0.0078245896111585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200R1,Cell surface glycoprotein CD200 receptor 1,21207,1858,0.89 [0.79-1.00],0.0454676892017768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD207,C-type lectin domain family 4 member K,20803,1824,1.16 [1.04-1.29],0.0065835085314191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD248,Endosialin,18498,1605,0.78 [0.70-0.87],7.339559685674736e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,21352,1860,1.51 [1.37-1.66],3.275283265475432e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,21104,1848,1.47 [1.30-1.67],1.1900066638151935e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD276,CD276 antigen,21262,1860,1.22 [1.08-1.37],0.0011382991314822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300A,CMRF35-like molecule 8,18077,1558,1.36 [1.16-1.59],0.000196958924626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,21484,1876,1.45 [1.29-1.62],2.095715943286578e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,21413,1871,1.45 [1.31-1.60],1.6834662119681358e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,21472,1876,1.21 [1.13-1.30],1.239775113234038e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,21186,1853,1.67 [1.47-1.91],6.710480674587462e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,21417,1871,0.77 [0.64-0.92],0.0033001593927819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD36,Platelet glycoprotein 4,17944,1562,1.11 [1.00-1.23],0.0461069134118587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,21251,1857,1.52 [1.33-1.75],2.114858617958854e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,21262,1859,1.21 [1.12-1.31],3.557697478406411e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40LG,CD40 ligand,21543,1879,1.07 [1.02-1.12],0.0098789079469516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD46,Membrane cofactor protein,21185,1845,1.18 [1.02-1.37],0.0271318861989231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD48,CD48 antigen,21336,1865,1.20 [1.04-1.37],0.0101514855374939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5,T-cell surface glycoprotein CD5,21442,1872,1.23 [1.10-1.37],0.0002783799941375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD55,Complement decay-accelerating factor,20561,1791,1.26 [1.06-1.49],0.0080683265451441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,20545,1789,1.52 [1.28-1.82],2.587344988479955e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5L,CD5 antigen-like,18425,1606,1.22 [1.10-1.34],0.0001142714848284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD63,CD63 antigen,21064,1844,1.09 [1.01-1.19],0.0338730093283964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD7,T-cell antigen CD7,17915,1559,1.29 [1.16-1.43],2.725556337701688e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD70,CD70 antigen,21282,1863,1.21 [1.10-1.33],7.981372768116404e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,21484,1876,1.56 [1.38-1.75],1.0764279606386841e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,21543,1879,1.14 [1.04-1.24],0.0032391133280025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,18494,1603,1.57 [1.37-1.81],2.8421592913384103e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,21282,1863,1.64 [1.48-1.81],5.649205006059136e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99,CD99 antigen,21302,1865,1.50 [1.22-1.85],0.0001372751794335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,21302,1865,1.95 [1.65-2.31],4.664287752961446e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDA,Cytidine deaminase,18465,1603,0.90 [0.82-0.99],0.0375286597412881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC27,Cell division cycle protein 27 homolog,20784,1814,1.07 [1.01-1.15],0.0328209099789051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,21104,1848,1.40 [1.31-1.50],2.3998148989952578e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH1,Cadherin-1,20587,1798,1.22 [1.11-1.35],2.8856562582246084e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,21289,1860,1.43 [1.28-1.60],6.903673526652141e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH5,Cadherin-5,21556,1882,0.82 [0.71-0.94],0.0044732870831627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,21186,1853,1.14 [1.07-1.21],6.400469450469807e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR5,Cadherin-related family member 5,21289,1860,0.87 [0.78-0.96],0.0074296231604393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,21322,1858,2.54 [2.10-3.07],8.2483283419173745e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,18435,1602,0.72 [0.68-0.76],2.0811687772805564e-32
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,18435,1602,1.13 [1.00-1.28],0.0451093838070626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,20784,1814,1.09 [1.00-1.19],0.042846323516029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,20519,1790,1.44 [1.36-1.52],4.334233778645655e-36
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,18498,1605,1.51 [1.34-1.70],4.604696158813423e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,20906,1832,1.30 [1.20-1.40],1.5869315465689658e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,18498,1605,1.20 [1.12-1.29],3.223334359121478e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,21521,1877,1.09 [1.01-1.16],0.0212832944230533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEMIP2,Cell surface hyaluronidase,17944,1562,1.22 [1.04-1.43],0.0154503046863495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEND1,Cell cycle exit and neuronal differentiation protein 1,17877,1545,1.10 [1.02-1.19],0.0126306897000279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP152,Centrosomal protein of 152 kDa,17841,1543,1.15 [1.03-1.27],0.0100543623399851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES1,Liver carboxylesterase 1,21353,1863,1.15 [1.09-1.20],1.0249138270281496e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES2,Cocaine esterase,21186,1853,1.13 [1.06-1.21],0.0004720012087383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFB,Complement factor B,18203,1588,1.79 [1.54-2.08],6.317554094460818e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFD,Complement factor D,18511,1612,1.62 [1.31-2.02],1.0293817837436744e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFH,Complement factor H,17473,1531,1.70 [1.37-2.11],1.795539526503076e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR5,Complement factor H-related protein 5,18281,1588,1.25 [1.11-1.41],0.0002093175175044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFI,Complement factor I,18511,1612,2.27 [1.77-2.92],1.1684618234970919e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFP,Properdin,18511,1612,0.79 [0.63-1.00],0.0472767384652294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGA,Glycoprotein hormones alpha chain,21302,1865,1.25 [1.17-1.33],2.4804245886881303e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGN,Cingulin,18001,1566,1.17 [1.04-1.31],0.0075903322156345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,21289,1860,1.20 [1.09-1.32],0.0002310262836604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAD,Chondroadherin,18077,1558,0.84 [0.76-0.94],0.0015098389475402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",18446,1599,1.58 [1.41-1.76],1.522802112825349e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,18419,1587,1.73 [1.50-2.01],1.45404361485121e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,18498,1605,1.17 [1.11-1.24],1.418214618170539e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,20839,1815,1.33 [1.28-1.39],4.871367700778677e-43
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,21336,1865,1.45 [1.28-1.65],1.1325166801971036e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,18498,1605,1.30 [1.19-1.42],9.171838137420558e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,21433,1870,1.62 [1.44-1.82],2.116534269411745e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,18498,1605,1.36 [1.25-1.47],1.9752035136050842e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",21192,1852,1.07 [1.00-1.13],0.0443600096205699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,21104,1848,1.36 [1.22-1.53],9.962144675433328e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC11A,C-type lectin domain family 11 member A,21273,1863,1.11 [1.02-1.20],0.0191855803338322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,21302,1865,1.46 [1.28-1.65],5.721742278522519e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,20906,1832,1.27 [1.12-1.44],0.0001699283750157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1B,C-type lectin domain family 1 member B,21484,1876,1.05 [1.00-1.09],0.0342759964852554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,18107,1578,0.60 [0.48-0.76],1.4614541354730328e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,21282,1863,0.88 [0.78-0.99],0.0315020232153563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4C,C-type lectin domain family 4 member C,21282,1863,1.09 [1.01-1.19],0.0341958569327154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,21282,1863,1.31 [1.24-1.38],3.1781733694355624e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,21214,1853,1.81 [1.61-2.03],1.4457474945221573e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,20784,1814,1.30 [1.20-1.41],9.349661119767828e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,21543,1879,1.12 [1.04-1.21],0.001967257955205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,18001,1566,1.28 [1.17-1.40],1.8877391969486085e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,21472,1876,1.69 [1.40-2.03],3.2755072414210256e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,21543,1879,1.39 [1.26-1.54],6.840326417751277e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,21393,1864,0.90 [0.83-0.98],0.0212386686464229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,21556,1882,0.64 [0.55-0.74],2.1178197187481403e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN3,Contactin-3,21302,1865,0.84 [0.73-0.97],0.0168652932722217
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,21344,1865,0.74 [0.66-0.83],2.081944125459691e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,21282,1863,1.10 [1.00-1.21],0.04163981852806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COCH,Cochlin,18494,1603,1.13 [1.03-1.25],0.0129628470196841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,21379,1865,2.26 [1.89-2.70],3.07084959473373e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,18435,1602,1.13 [1.04-1.23],0.004886061783592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,21289,1860,1.40 [1.26-1.55],2.4599659002019116e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL5A1,Collagen alpha-1(V) chain,18077,1558,1.32 [1.17-1.48],8.493035540814105e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,21556,1882,1.54 [1.38-1.73],1.081128934547662e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,21282,1863,1.15 [1.05-1.27],0.0036295448395723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,21262,1860,1.70 [1.46-1.98],3.601432770093104e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMT,Catechol O-methyltransferase,20673,1815,1.05 [1.00-1.11],0.0395477862853459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",17992,1559,1.26 [1.13-1.42],5.3062966535398207e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO1A,Coronin-1A,20881,1814,1.06 [1.02-1.11],0.0086256583801246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",21186,1853,1.09 [1.03-1.15],0.0035641154009983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA1,Carboxypeptidase A1,21556,1882,1.17 [1.11-1.24],1.5867327175233264e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA4,Carboxypeptidase A4,17726,1533,0.86 [0.77-0.96],0.0082223828643871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB1,Carboxypeptidase B,21556,1882,1.14 [1.07-1.22],4.3405447134271024e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB2,Carboxypeptidase B2,18483,1611,1.25 [1.01-1.55],0.0397341473809588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,21373,1862,1.39 [1.23-1.56],4.980254865607672e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",17944,1562,1.23 [1.02-1.48],0.0330716075672217
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPQ,Carboxypeptidase Q,18468,1602,1.27 [1.12-1.45],0.0002831166011104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,21428,1871,1.23 [1.11-1.36],7.457810483324264e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM1,Probable carboxypeptidase X1,21352,1860,1.08 [1.02-1.15],0.0059511515090504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,18494,1603,1.37 [1.15-1.64],0.0005012494620654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR2,Complement receptor type 2,21393,1864,0.85 [0.78-0.93],0.0002900254841737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,21021,1832,1.42 [1.30-1.55],5.301848940107103e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,18077,1558,1.29 [1.13-1.46],0.0001414926115239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,21336,1865,1.14 [1.05-1.24],0.0012806545553355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRH,Corticoliberin,20747,1812,0.93 [0.89-0.98],0.0060637648241419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,21262,1860,1.49 [1.28-1.73],1.971093500102148e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,21367,1868,1.64 [1.33-2.02],3.2746022752650365e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIP2,Cysteine-rich protein 2,21104,1848,1.26 [1.13-1.40],4.53916637657646e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,21472,1876,0.92 [0.85-0.98],0.0161915368831968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,18340,1587,0.74 [0.62-0.88],0.0007620698070846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRLF1,Cytokine receptor-like factor 1,21367,1868,1.18 [1.01-1.39],0.0387376063091974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB2,Beta-crystallin B2,18446,1599,1.07 [1.00-1.15],0.0468229076165445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,21367,1868,1.55 [1.34-1.79],2.232348856039536e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,21104,1848,1.13 [1.05-1.21],0.000753088604225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,17944,1562,1.38 [1.18-1.62],6.881685533876112e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,18498,1605,0.78 [0.69-0.89],0.0002486017595358
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST1,Cystatin-SN,16094,1383,0.90 [0.86-0.95],0.0001235330060886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,21354,1860,1.69 [1.46-1.96],1.3377699849772708e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,21293,1862,1.11 [1.07-1.16],4.290863218298733e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,21003,1829,1.33 [1.21-1.46],1.9879303655653486e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTBS,Di-N-acetylchitobiase,18249,1584,1.21 [1.00-1.45],0.0491843824251311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,18498,1605,1.48 [1.25-1.76],5.583346735556716e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRB1,Chymotrypsinogen B,21302,1865,1.09 [1.02-1.16],0.011362354509535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,18446,1599,0.92 [0.87-0.98],0.0118330880794679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSB,Cathepsin B,21308,1858,1.17 [1.08-1.26],6.67338110244078e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSC,Dipeptidyl peptidase 1,21215,1858,1.23 [1.13-1.35],5.126796964459806e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,19923,1746,1.60 [1.49-1.72],3.811023792171941e-37
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSF,Cathepsin F,21352,1860,1.31 [1.19-1.44],3.4155759249838056e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSH,Pro-cathepsin H,20830,1823,1.09 [1.03-1.15],0.0030467076236174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,21289,1860,1.51 [1.28-1.79],1.5448624215213983e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSO,Cathepsin O,21543,1879,1.31 [1.16-1.47],8.461703504550805e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSS,Cathepsin S,16769,1472,1.36 [1.10-1.69],0.0051073132956658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,21328,1859,1.42 [1.25-1.61],7.253866889562234e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,21282,1863,1.52 [1.41-1.64],6.392150751524309e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL10,C-X-C motif chemokine 10,21367,1868,1.12 [1.06-1.19],0.0001492696602838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL11,C-X-C motif chemokine 11,21484,1876,1.11 [1.06-1.16],3.166460934136106e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL12,Stromal cell-derived factor 1,20914,1833,1.25 [1.13-1.39],2.3301617112224253e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,21484,1876,1.13 [1.06-1.21],0.0001273346209466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL14,C-X-C motif chemokine 14,20914,1833,1.12 [1.05-1.19],0.000411134461993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,21521,1879,1.94 [1.63-2.31],5.6136324297638343e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,21543,1879,1.88 [1.77-2.00],3.275049089443917e-89
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,21138,1850,1.15 [1.09-1.21],2.20305786372384e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,21367,1868,1.20 [1.13-1.27],1.7996934554018071e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5A,Cytochrome b5,17841,1543,1.09 [1.02-1.16],0.0104211703163824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,18241,1582,1.14 [1.06-1.23],0.0008623803348814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTL1,Cytokine-like protein 1,18498,1605,1.23 [1.02-1.49],0.0298669248400349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAG1,Dystroglycan,21367,1868,1.13 [1.04-1.23],0.0056511881105697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBI,Acyl-CoA-binding protein,21204,1853,1.09 [1.03-1.14],0.0018838935858288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",21352,1860,1.32 [1.17-1.48],4.618363738361272e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D1,DCN1-like protein 1,17877,1545,0.91 [0.84-0.98],0.0178000858473894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCXR,L-xylulose reductase,21352,1860,1.08 [1.01-1.16],0.0289770227303639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",21186,1853,1.35 [1.24-1.47],5.539014499564652e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,21484,1876,1.93 [1.65-2.26],3.8775744660822236e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDT,D-dopachrome decarboxylase,18498,1605,1.16 [1.04-1.29],0.0085474647071937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX4,Probable ATP-dependent RNA helicase DDX4,17944,1562,0.90 [0.82-1.00],0.0416341038322038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",21282,1863,1.07 [1.02-1.11],0.0028365276163549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,20875,1819,1.13 [1.06-1.22],0.0004432227631558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB104A_DEFB104B,Beta-defensin 104,17877,1545,0.89 [0.81-0.98],0.0171943807449841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,20974,1838,1.04 [1.01-1.07],0.0031148977119989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGCR6,Protein DGCR6,17877,1545,1.14 [1.01-1.29],0.0345473159713476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKA,Diacylglycerol kinase alpha,17944,1562,1.09 [1.00-1.19],0.0448069115036535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK3,Dickkopf-related protein 3,21556,1882,0.84 [0.73-0.97],0.0161380339817468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLK1,Protein delta homolog 1,21556,1882,0.83 [0.78-0.89],3.511883536562847e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,21352,1860,1.36 [1.19-1.55],6.6259219011472746e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMD,Dystrophin,17992,1559,1.11 [1.01-1.23],0.0347682879926269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,17992,1559,0.83 [0.76-0.90],4.927662397022356e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB14,DnaJ homolog subfamily B member 14,18435,1602,1.09 [1.02-1.17],0.0133842965378359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,21222,1859,0.80 [0.68-0.93],0.0047307220840281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM3,Dynamin-3,18454,1594,1.12 [1.03-1.22],0.0088402057829349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNMBP,Dynamin-binding protein,21104,1848,1.09 [1.02-1.17],0.0102151513309478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP1,Dipeptidase 1,21075,1846,0.86 [0.79-0.94],0.0005349073148708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,21282,1863,1.53 [1.39-1.69],1.9517218339687493e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,21186,1853,0.73 [0.64-0.82],3.931794603734336e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,21129,1847,1.30 [1.21-1.38],1.9196704211169163e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,21415,1872,1.17 [1.10-1.25],9.158952307125282e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSC2,Desmocollin-2,21041,1848,1.20 [1.07-1.35],0.0018895413331135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG2,Desmoglein-2,21302,1865,0.83 [0.71-0.98],0.0234706932494647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG3,Desmoglein-3,21404,1868,0.83 [0.73-0.93],0.0013140073185867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,18380,1585,1.28 [1.15-1.42],4.389778480473695e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,21186,1853,1.59 [1.37-1.84],6.959410528649593e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",18494,1603,1.26 [1.19-1.33],5.150013950349291e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",17992,1559,1.14 [1.09-1.20],2.130906787763486e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECI2,Enoyl-CoA delta isomerase 2,17856,1551,1.12 [1.05-1.20],0.0011261232352889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,21472,1876,1.39 [1.25-1.55],1.664949468008948e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,21282,1863,0.93 [0.89-0.97],0.0017746060397833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,20906,1832,1.44 [1.31-1.58],3.0400917572590486e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,17992,1559,2.09 [1.79-2.45],6.817887864573586e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EEF1D,Elongation factor 1-delta,18494,1603,1.09 [1.03-1.14],0.0011230131249245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,18435,1602,1.38 [1.16-1.64],0.0003221433300601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,21359,1861,1.45 [1.28-1.65],1.1604234946054592e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,21263,1858,1.73 [1.50-1.99],1.6698148874377204e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,21064,1844,1.64 [1.45-1.85],2.5360025392767626e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,20784,1814,1.34 [1.20-1.48],7.226170269304914e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFLAM,Pikachurin,18435,1602,1.31 [1.12-1.52],0.000588413803413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,21556,1882,0.44 [0.34-0.56],1.4448673519075063e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,21282,1863,1.17 [1.11-1.24],7.3609377546572706e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",18362,1594,1.06 [1.01-1.10],0.0093259291375821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,21289,1860,1.15 [1.09-1.23],4.190329734937211e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,21543,1879,1.06 [1.01-1.10],0.0105851246257454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELAVL4,ELAV-like protein 4,17877,1545,1.07 [1.01-1.14],0.0165749329519597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,18494,1603,1.39 [1.21-1.60],3.114330645074164e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOA,Elongin-A,21186,1853,1.12 [1.05-1.20],0.0003238414844521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENAH,Protein enabled homolog,20914,1833,1.15 [1.06-1.26],0.0012999950475586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,17070,1465,0.85 [0.78-0.94],0.0008241957271737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENG,Endoglin,21556,1882,1.37 [1.09-1.74],0.0081771166107583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO3,Beta-enolase,17992,1559,0.90 [0.83-0.98],0.0121118452915718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOPH1,Enolase-phosphatase E1,18419,1587,0.88 [0.79-0.99],0.0311246881128643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPEP,Glutamyl aminopeptidase,17856,1551,1.18 [1.07-1.30],0.0010506803995156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,21556,1882,1.29 [1.09-1.52],0.0027038098744809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,21367,1868,0.79 [0.73-0.85],1.695822192445541e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,20647,1804,1.22 [1.16-1.28],4.566957854157812e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,20784,1814,1.21 [1.10-1.33],4.734962329870297e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,20906,1832,1.27 [1.08-1.49],0.0032836884807681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,17992,1559,1.09 [1.01-1.17],0.0251196532596251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,20504,1782,1.47 [1.29-1.68],5.125641405220269e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA4,Ephrin type-A receptor 4,18077,1558,0.73 [0.62-0.87],0.0002735850470827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,21556,1882,1.41 [1.20-1.66],2.37741017279423e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPO,Erythropoietin,21282,1863,1.10 [1.05-1.16],0.0001872667095266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPPK1,Epiplakin,17992,1559,1.08 [1.01-1.14],0.01424925886073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,21439,1873,1.50 [1.32-1.70],5.895328436939694e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,21352,1860,1.75 [1.49-2.07],2.809173002572884e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,21178,1853,1.50 [1.22-1.84],0.0001334244176977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERI1,3'-5' exoribonuclease 1,18165,1571,1.27 [1.12-1.44],0.0002417921588029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,21556,1882,1.17 [1.03-1.32],0.0151565498728138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXTL1,Exostosin-like 1,17856,1551,0.82 [0.72-0.92],0.0010926054919345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EZR,Ezrin,21484,1876,1.48 [1.27-1.72],4.98361945863919e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11R,Junctional adhesion molecule A,21302,1865,1.13 [1.05-1.22],0.0007324082631597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F12,Coagulation factor XII,18511,1612,1.17 [1.04-1.31],0.0079384260738105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F13B,Coagulation factor XIII B chain,18425,1606,1.26 [1.05-1.51],0.0131562224287181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2R,Proteinase-activated receptor 1,21336,1865,1.09 [1.01-1.16],0.0198058805208688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F3,Tissue factor,21334,1863,1.17 [1.00-1.37],0.046186313676336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,21360,1861,1.99 [1.57-2.52],9.531242116824029e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",21262,1860,1.18 [1.14-1.23],4.769192859970308e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",21289,1860,1.08 [1.03-1.14],0.0031851941001519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",18494,1603,1.21 [1.11-1.32],1.101139333144466e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",21556,1882,1.42 [1.31-1.54],1.1436300237805492e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP5,Fatty acid-binding protein 5,21410,1872,1.15 [1.09-1.22],1.7802970003250555e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171A2,Protein FAM171A2,18454,1594,1.05 [1.02-1.08],0.001213103866753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,18494,1603,2.03 [1.76-2.34],6.42052920738819e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,21186,1853,1.35 [1.20-1.52],6.690515029125384e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,21260,1858,1.44 [1.25-1.65],2.927539378246036e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3D,Protein FAM3D,18435,1602,1.09 [1.03-1.15],0.003614097147278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAP,Prolyl endopeptidase FAP,21556,1882,0.76 [0.65-0.88],0.0002752140209449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,21543,1879,0.75 [0.68-0.83],2.1466382211993644e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",21289,1860,1.10 [1.04-1.17],0.0004338760347192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,21282,1863,1.19 [1.10-1.30],5.4794457584795634e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,21321,1857,1.10 [1.01-1.20],0.021607427701792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,18480,1603,1.41 [1.28-1.54],1.3448471618544e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN2,Ficolin-2,21213,1856,1.15 [1.03-1.27],0.0104642935739485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL1,Fc receptor-like protein 1,21289,1860,0.89 [0.81-0.98],0.0136531345754727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL5,Fc receptor-like protein 5,21302,1865,1.09 [1.02-1.17],0.0122168443496891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,20784,1814,1.18 [1.10-1.25],4.361862098445488e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGA,Fibrinogen alpha chain,18100,1579,1.65 [1.41-1.93],2.9499321277154863e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF19,Fibroblast growth factor 19,21367,1868,1.10 [1.05-1.16],0.0003537520190957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF2,Fibroblast growth factor 2,21282,1863,1.11 [1.04-1.17],0.0005282215979395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,21448,1875,1.24 [1.21-1.28],2.222465660101435e-50
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,21433,1872,1.30 [1.22-1.39],3.9339001466816695e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF5,Fibroblast growth factor 5,20914,1833,1.28 [1.13-1.45],6.105854408007679e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF7,Fibroblast growth factor 7,17841,1543,1.06 [1.00-1.12],0.0485385735423993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,21352,1860,0.79 [0.71-0.89],6.077750580450361e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,21352,1860,1.93 [1.61-2.31],1.6642824732183982e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,18509,1603,1.36 [1.27-1.46],3.4234819349577705e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGR,Tyrosine-protein kinase Fgr,20838,1837,1.09 [1.03-1.16],0.0035747153083043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FIS1,Mitochondrial fission 1 protein,21253,1858,1.12 [1.06-1.18],1.764531988104242e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,18454,1594,1.05 [1.00-1.10],0.0359172743711344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,21104,1848,1.17 [1.06-1.30],0.0017087804485596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,21104,1848,1.06 [1.01-1.11],0.0121795400175806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,21146,1850,1.32 [1.09-1.59],0.0040126874937323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3,Receptor-type tyrosine-protein kinase FLT3,20784,1814,0.85 [0.73-0.97],0.0192078746714297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FMNL1,Formin-like protein 1,20838,1837,1.07 [1.01-1.13],0.0218661867182805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FN1,Fibronectin,18511,1612,1.21 [1.01-1.44],0.0419486431555755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,18446,1599,1.12 [1.01-1.25],0.0248534883737455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR1,Folate receptor alpha,21272,1850,1.18 [1.03-1.35],0.0202830329064299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR2,Folate receptor beta,21484,1876,1.30 [1.13-1.49],0.000179357911023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FST,Follistatin,21336,1865,1.29 [1.19-1.40],8.126154594804264e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,17992,1559,1.93 [1.56-2.38],1.0109034943845634e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,21234,1859,2.00 [1.78-2.26],5.7320351072475696e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,18407,1597,1.10 [1.05-1.16],0.0002209688694763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,18077,1558,1.18 [1.10-1.28],1.765143546141388e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FURIN,Furin,21352,1860,1.49 [1.32-1.68],4.6671324327282766e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUS,RNA-binding protein FUS,20745,1810,1.19 [1.08-1.31],0.000596873538389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,21484,1876,1.46 [1.34-1.59],5.73592040288285e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,17992,1559,1.12 [1.02-1.22],0.015028064912165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAL,Galanin peptides,21367,1868,0.86 [0.81-0.92],2.157813314567233e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,21186,1853,1.65 [1.43-1.91],6.7875420023001755e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,21472,1876,0.69 [0.60-0.81],2.817501845661146e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,18494,1603,1.24 [1.05-1.48],0.0130329455951033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,17677,1530,1.31 [1.09-1.57],0.0036283027318575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS6,Growth arrest-specific protein 6,21422,1870,1.60 [1.36-1.89],1.05820535588202e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,18446,1599,1.14 [1.10-1.18],3.4151348196417936e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP1,Guanylate-binding protein 1,18412,1597,1.16 [1.07-1.25],0.000178848737483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,17628,1527,1.35 [1.25-1.46],1.549766576946533e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",21186,1853,1.20 [1.06-1.35],0.0032922336401611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,21556,1882,1.87 [1.74-2.01],3.3794484203003573e-65
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF2,Growth/differentiation factor 2,21289,1860,1.20 [1.07-1.34],0.0022156574831903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,20838,1837,1.14 [1.02-1.28],0.0186575859278052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,20784,1814,1.20 [1.12-1.27],1.5771202576534942e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,21448,1875,1.76 [1.52-2.03],1.0407044916291436e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA3,GDNF family receptor alpha-3,21040,1845,0.82 [0.71-0.96],0.0133532114568302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,17928,1551,0.79 [0.73-0.86],3.778159743738788e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGH,Gamma-glutamyl hydrolase,20937,1828,1.19 [1.06-1.35],0.0037685807699841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,21263,1858,1.52 [1.41-1.63],4.233668379514344e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,21104,1848,1.82 [1.55-2.14],6.078900160340499e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHR,Growth hormone receptor,18077,1558,0.77 [0.65-0.90],0.001497889050222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRL,Appetite-regulating hormone,21289,1860,1.06 [1.01-1.12],0.0198119372165588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIGYF2,GRB10-interacting GYF protein 2,18454,1594,1.08 [1.02-1.15],0.0142539002572882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIMAP8,GTPase IMAP family member 8,17841,1543,1.14 [1.05-1.25],0.0028179774627736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,18446,1599,1.54 [1.34-1.77],2.007598310378864e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GKN1,Gastrokine-1,20455,1792,1.33 [1.13-1.55],0.0004506611916148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,18046,1554,1.32 [1.17-1.50],8.852766531778585e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,21104,1848,1.21 [1.11-1.33],4.760923898999434e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,20906,1832,1.22 [1.14-1.32],3.0870429410318184e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",18077,1558,1.06 [1.01-1.12],0.0199732173469335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,18049,1563,1.32 [1.16-1.51],3.1370733896826285e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,20784,1814,1.07 [1.01-1.14],0.0323932222623503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLM2,Protein GOLM2,21484,1876,1.75 [1.45-2.10],3.1757904231089063e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC1,Glypican-1,21472,1876,0.84 [0.72-0.96],0.0127847310630195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC5,Glypican-5,21104,1848,0.86 [0.80-0.92],4.243432110470191e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,18419,1587,1.29 [1.19-1.41],2.117589489337127e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPI,Glucose-6-phosphate isomerase,18509,1603,1.11 [1.01-1.22],0.023116850777088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,20838,1837,1.34 [1.20-1.49],1.6309334394948284e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR15L,Protein GPR15L,18435,1602,1.14 [1.06-1.23],0.0004243374481
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,20906,1832,1.28 [1.20-1.37],1.1121950813652836e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,18419,1587,1.34 [1.25-1.45],2.87216090188439e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRK5,G protein-coupled receptor kinase 5,20906,1832,1.08 [1.00-1.17],0.0459659467190035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRN,Progranulin,21191,1854,1.71 [1.47-2.00],1.0394122934355395e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRP,Gastrin-releasing peptide,17992,1559,1.15 [1.05-1.25],0.0023297146126782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",21186,1853,1.36 [1.28-1.44],3.4102852617392656e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,18433,1597,0.47 [0.36-0.61],1.1036694050966376e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSR,"Glutathione reductase, mitochondrial",18414,1596,1.25 [1.01-1.54],0.0389357478776579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA1,Glutathione S-transferase A1,21257,1856,1.06 [1.01-1.11],0.0256679367497678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,18165,1571,1.09 [1.02-1.16],0.0101490075160007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCA2A,Guanylin,21191,1857,1.24 [1.10-1.40],0.0003674805408862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,21379,1864,1.19 [1.11-1.27],5.618940256335535e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,21472,1876,1.10 [1.06-1.13],2.3655327809943092e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,21442,1872,1.38 [1.30-1.46],6.207107131494159e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,21302,1865,1.60 [1.43-1.79],5.455832177574557e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBEGF,Proheparin-binding EGF-like growth factor,21418,1871,0.94 [0.89-1.00],0.0404365859730975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,18077,1558,1.79 [1.52-2.12],7.247215872842079e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPH,Hephaestin,18494,1603,1.37 [1.14-1.65],0.0006717331975234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,21543,1879,1.74 [1.57-1.94],7.148981022630269e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,20784,1814,1.07 [1.01-1.12],0.0149095571185765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HHEX,Hematopoietically-expressed homeobox protein HHEX,18446,1599,1.08 [1.01-1.15],0.0201932124757088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,18409,1595,1.25 [1.16-1.35],1.242425338952074e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HJV,Hemojuvelin,18454,1594,1.25 [1.12-1.40],6.143881517062138e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",18454,1594,1.16 [1.00-1.34],0.0441142593061124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",21215,1854,1.15 [1.03-1.29],0.0138241204455367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",21282,1863,1.37 [1.19-1.58],1.3212876374271651e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",17992,1559,1.14 [1.03-1.26],0.0090529016847597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX1,Heme oxygenase 1,21048,1837,1.16 [1.07-1.25],0.000325119071667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX2,Heme oxygenase 2,20838,1837,1.27 [1.17-1.37],7.484836120686084e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNMT,Histamine N-methyltransferase,21009,1839,1.23 [1.13-1.34],1.1188334502838994e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,18454,1594,1.14 [1.04-1.25],0.0065154438982466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,20784,1814,0.72 [0.64-0.80],3.898432402535657e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPSE,Heparanase,18273,1588,1.11 [1.06-1.17],6.157194081416053e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,17992,1559,0.86 [0.75-1.00],0.0497361150306975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,21186,1853,1.31 [1.17-1.46],2.23645668637774e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,17944,1562,0.87 [0.76-1.00],0.0461481483396339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,21282,1863,1.34 [1.22-1.48],2.1624800569974643e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,18446,1599,1.19 [1.10-1.28],2.160408462958214e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB6,Heat shock protein beta-6,21472,1876,1.16 [1.04-1.28],0.0053983622532241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,21148,1845,1.49 [1.27-1.75],7.362002352043332e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTR1B,5-hydroxytryptamine receptor 1B,17877,1545,0.81 [0.71-0.93],0.0022266775046965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",21352,1860,1.13 [1.06-1.21],0.0002491771899496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,21201,1850,1.69 [1.42-2.01],2.2323530372402198e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,21556,1882,1.32 [1.11-1.58],0.0019332261579162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,21210,1850,2.00 [1.76-2.27],2.546835259984649e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM3,Intercellular adhesion molecule 3,21556,1882,1.42 [1.23-1.64],2.957292923993683e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,21289,1860,1.57 [1.44-1.72],1.7765131969065549e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,21472,1876,1.30 [1.19-1.42],5.927045190403722e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,17992,1562,1.81 [1.61-2.03],2.461732210879028e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNG,Interferon gamma,20914,1833,1.05 [1.02-1.09],0.0043265058483933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR1,Interferon gamma receptor 1,21367,1868,1.23 [1.01-1.49],0.0412922924514633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR2,Interferon gamma receptor 2,21104,1848,1.25 [1.16-1.34],6.0507830628851035e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNLR1,Interferon lambda receptor 1,21282,1863,1.28 [1.15-1.42],4.28834788638901e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,18498,1605,0.63 [0.55-0.72],2.0986448915579057e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,21302,1865,1.80 [1.51-2.14],2.059683551656261e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,21523,1879,1.13 [1.10-1.17],3.798885734221944e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,21527,1880,1.31 [1.22-1.41],1.2146821373363395e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,21393,1864,0.84 [0.74-0.95],0.0059274812525696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,21040,1846,1.70 [1.56-1.84],5.468718482429783e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,21556,1882,1.77 [1.58-1.99],3.692313672895786e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,21289,1860,1.83 [1.63-2.06],6.112365876115972e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,18488,1607,1.61 [1.43-1.81],3.1499551243414204e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLON5,IgLON family member 5,17841,1543,1.06 [1.00-1.11],0.0340537257333295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF21,Immunoglobulin superfamily member 21,17992,1559,0.83 [0.73-0.94],0.003441239939937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,21186,1853,1.37 [1.24-1.51],6.851267846537499e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,21289,1860,1.63 [1.45-1.84],6.735605727270674e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,18494,1603,1.18 [1.12-1.24],2.907847834240272e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10,Interleukin-10,20914,1833,1.08 [1.03-1.13],0.0025677133516996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RA,Interleukin-10 receptor subunit alpha,20914,1833,1.07 [1.00-1.15],0.0464340401076241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,21367,1868,1.64 [1.43-1.88],1.2065580837400444e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL11,Interleukin-11,20914,1833,1.08 [1.01-1.16],0.01827228590116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12B,Interleukin-12 subunit beta,21543,1879,0.93 [0.87-1.00],0.0405423914289057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB2,Interleukin-12 receptor subunit beta-2,17944,1562,0.88 [0.78-0.99],0.0383678922696774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA1,Interleukin-13 receptor subunit alpha-1,21037,1830,1.22 [1.04-1.44],0.0170620686618614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,21282,1863,1.75 [1.55-1.99],2.6458748021056482e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,20914,1833,1.27 [1.13-1.43],6.944535193456601e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL16,Pro-interleukin-16,21543,1879,1.13 [1.03-1.23],0.0073434844218366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17C,Interleukin-17C,20914,1833,1.08 [1.02-1.15],0.0066017181211595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17F,Interleukin-17F,20914,1833,1.06 [1.00-1.11],0.0338484048113178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,21191,1854,1.25 [1.14-1.37],1.262158437893223e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,21393,1864,1.47 [1.28-1.68],1.7418996181076335e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,21543,1879,1.32 [1.17-1.49],7.372288167433801e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,20757,1817,1.17 [1.11-1.23],1.0733468870069972e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1B,Interleukin-1 beta,20814,1828,1.11 [1.04-1.19],0.0010229544459891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R1,Interleukin-1 receptor type 1,21263,1858,1.53 [1.28-1.83],2.91412904413348e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R2,Interleukin-1 receptor type 2,21221,1856,1.61 [1.30-1.98],9.373614434243078e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,21302,1865,0.90 [0.82-0.99],0.0232309362360768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,21480,1875,1.36 [1.25-1.49],4.5376241535448476e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,20914,1833,0.72 [0.64-0.80],1.0020543267178531e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,21217,1857,1.32 [1.24-1.41],2.293909117574644e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2,Interleukin-2,20914,1833,1.16 [1.01-1.33],0.0352731388168245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,18419,1587,1.27 [1.20-1.35],2.6562140192312376e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22RA1,Interleukin-22 receptor subunit alpha-1,20914,1833,1.09 [1.01-1.19],0.0342031980096379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL25,Interleukin-25,17777,1534,1.21 [1.05-1.40],0.0097774300477878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,21147,1853,1.52 [1.39-1.67],2.660471313574346e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,21282,1863,1.31 [1.20-1.43],1.0773871749494176e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,21282,1863,1.64 [1.48-1.81],2.8422862765919256e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,21186,1853,1.29 [1.24-1.33],4.067421800254431e-43
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,21289,1860,1.79 [1.42-2.28],1.377725850660147e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,21302,1865,0.83 [0.78-0.90],1.115794793778192e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,20803,1836,1.08 [1.01-1.16],0.0314467557652237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,18419,1587,1.43 [1.30-1.57],4.1619457618142054e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPG1,Interphotoreceptor matrix proteoglycan 1,17877,1545,0.82 [0.69-0.98],0.0254087514034779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,18077,1558,1.50 [1.37-1.64],1.0062355565631624e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",17992,1559,1.12 [1.03-1.21],0.0066339497848153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL3,Insulin-like 3,18446,1599,0.88 [0.83-0.92],8.459151891045316e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,18435,1602,1.16 [1.10-1.21],1.225880163804642e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSR,Insulin receptor,17944,1562,2.11 [1.57-2.85],9.803299082514905e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IPCEF1,Interactor protein for cytohesin exchange factors 1,21064,1844,1.05 [1.00-1.10],0.0302432198360363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IQGAP2,Ras GTPase-activating-like protein IQGAP2,21186,1853,1.10 [1.02-1.18],0.0146677769851293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",20906,1832,1.05 [1.01-1.10],0.0283993097573454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK1,Interleukin-1 receptor-associated kinase 1,20914,1833,1.06 [1.00-1.13],0.0404718712847968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM1,Isthmin-1,21282,1863,1.23 [1.10-1.36],0.0001237264183746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,21282,1863,0.74 [0.65-0.83],7.773694790048251e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA2,Integrin alpha-2,18077,1558,0.81 [0.71-0.94],0.0042448662051574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA5,Integrin alpha-5,21302,1865,1.71 [1.45-2.01],1.0014473146177576e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAM,Integrin alpha-M,21302,1865,0.86 [0.76-0.98],0.0256206420862748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,21472,1876,0.63 [0.50-0.80],0.0001476382680835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAX,Integrin alpha-X,18165,1571,1.13 [1.04-1.23],0.0039632576468823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,18498,1605,1.48 [1.31-1.66],1.2965115185344754e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,21393,1864,1.40 [1.26-1.56],1.5317029777707015e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,18511,1612,1.46 [1.20-1.77],0.0001486716669213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPA,Inosine triphosphate pyrophosphatase,17856,1551,1.11 [1.03-1.19],0.0048740161169724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM3,Junctional adhesion molecule C,18077,1558,1.14 [1.04-1.24],0.0057914266099394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JCHAIN,Immunoglobulin J chain,20914,1833,1.19 [1.11-1.27],5.121408418441717e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JUN,Transcription factor AP-1,20914,1833,1.10 [1.01-1.20],0.0320888360714907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,21186,1853,0.79 [0.72-0.86],7.71312717850037e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZN,Kazrin,18435,1602,1.05 [1.00-1.10],0.0368993388629395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCTD5,BTB/POZ domain-containing protein KCTD5,18099,1569,1.14 [1.04-1.25],0.0046796884194521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KDR,Vascular endothelial growth factor receptor 2,21352,1860,1.19 [1.01-1.39],0.0357280380483216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHK,Ketohexokinase,17992,1559,1.10 [1.02-1.19],0.015570302239479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF1C,Kinesin-like protein KIF1C,17856,1551,1.19 [1.04-1.35],0.0098247954840648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,20784,1814,1.07 [1.02-1.13],0.0116290617878409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,21289,1860,0.61 [0.55-0.68],3.7724485926779377e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLF4,Krueppel-like factor 4,17877,1545,1.16 [1.05-1.29],0.0048655930175574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLHL41,Kelch-like protein 41,18454,1594,0.89 [0.80-0.98],0.0230752671087419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,21296,1851,1.31 [1.19-1.44],6.145011623439087e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,21147,1841,1.36 [1.20-1.54],1.5757152774437568e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK13,Kallikrein-13,20796,1826,1.17 [1.06-1.28],0.0012122770910786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK14,Kallikrein-14,21472,1876,1.17 [1.08-1.28],0.0002634028980128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,21472,1876,1.28 [1.20-1.36],5.993829437570933e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK6,Kallikrein-6,21310,1858,0.87 [0.77-0.98],0.0227741769786529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK8,Kallikrein-8,20576,1790,1.26 [1.12-1.41],0.0001230535262215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",21186,1853,1.18 [1.12-1.23],3.6368160993693443e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",21245,1861,1.17 [1.11-1.24],9.37035150797924e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",17877,1545,1.12 [1.06-1.18],2.834862464460061e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,21543,1879,1.25 [1.14-1.36],7.015518330270018e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,18494,1603,1.07 [1.01-1.12],0.0159852230956098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,21262,1860,1.40 [1.28-1.54],4.1828412619027753e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,21104,1848,1.08 [1.04-1.13],0.0001252907072334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,21367,1868,1.34 [1.20-1.50],2.619078644142179e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,17987,1563,1.36 [1.12-1.64],0.0018697447031386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,20630,1802,1.57 [1.27-1.93],2.15232552056522e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,21507,1876,1.53 [1.43-1.63],2.883335196409524e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAP3,Cytosol aminopeptidase,20914,1833,1.11 [1.02-1.21],0.0174020843934402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LARP1,La-related protein 1,18419,1587,1.09 [1.01-1.17],0.0208755491771188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT2,Linker for activation of T-cells family member 2,21186,1853,1.03 [1.00-1.07],0.0440194021437701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,21075,1846,1.45 [1.29-1.63],4.790475484873021e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBP,Lipopolysaccharide-binding protein,21393,1864,1.13 [1.05-1.21],0.0008594583682804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBR,Delta(14)-sterol reductase LBR,21484,1876,1.12 [1.06-1.18],3.4067011835288654e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN15,Lipocalin-15,18454,1594,1.11 [1.03-1.20],0.0055309227130695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,20655,1806,1.28 [1.16-1.42],1.773316512894721e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCP1,Plastin-2,18498,1605,1.12 [1.02-1.23],0.0137277097819321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,18494,1603,1.21 [1.12-1.30],3.1664255020794626e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEG1,Protein LEG1 homolog,17489,1509,1.21 [1.13-1.29],3.4855013310226344e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEO1,RNA polymerase-associated protein LEO1,18454,1594,1.21 [1.03-1.42],0.019923156150308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEPR,Leptin receptor,21289,1860,1.24 [1.10-1.41],0.000548175037221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,18454,1594,1.22 [1.12-1.33],6.80439539882329e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS1,Galectin-1,21289,1860,1.37 [1.22-1.53],6.185537625875846e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,21351,1863,1.37 [1.20-1.58],5.066050021936826e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,18511,1612,1.65 [1.44-1.89],1.804187997367753e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,21262,1860,1.41 [1.31-1.51],6.167118166688228e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS7_LGALS7B,Galectin-7,21232,1857,1.14 [1.04-1.24],0.0051948877081362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,21262,1859,1.66 [1.47-1.87],8.382829351399623e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,21367,1868,1.58 [1.42-1.76],2.0021045287318265e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHB,Lutropin subunit beta,20784,1814,1.06 [1.01-1.11],0.0156935550464586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,21291,1863,1.11 [1.04-1.19],0.001863816441435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIF,Leukemia inhibitory factor,20838,1837,1.17 [1.08-1.26],0.0001093580472434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIFR,Leukemia inhibitory factor receptor,21282,1863,1.34 [1.14-1.58],0.0003737327086559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,21302,1865,1.18 [1.05-1.33],0.0051575946438132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,21260,1858,1.57 [1.39-1.78],7.465412109411168e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,18494,1603,1.09 [1.02-1.16],0.0121214370084935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,21556,1882,1.43 [1.23-1.66],2.178052877490233e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,21451,1873,1.35 [1.20-1.53],1.033263384945856e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,20914,1833,1.31 [1.19-1.43],1.5554995315761026e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,18446,1599,1.52 [1.28-1.80],1.7574709423251446e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD1,Leiomodin-1,18454,1594,1.33 [1.18-1.51],6.000873146332103e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",17992,1559,1.09 [1.03-1.15],0.0023201058328897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,21186,1853,1.10 [1.02-1.19],0.0133603491364945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPO,Lactoperoxidase,20532,1798,1.11 [1.04-1.19],0.0023312151362918
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,17856,1551,1.11 [1.04-1.19],0.0021870922033939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,18001,1566,0.89 [0.80-1.00],0.0455876190486548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,18511,1612,1.83 [1.54-2.17],4.574727137629129e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,21418,1871,1.15 [1.02-1.29],0.0212754208966686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,21186,1853,1.29 [1.12-1.50],0.0005172653276238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,21289,1860,1.22 [1.09-1.37],0.0006138808951385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,21484,1876,1.12 [1.05-1.20],0.0003981348123682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,21186,1853,1.33 [1.20-1.47],3.7758982707198086e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC37A2,Leucine-rich repeat-containing protein 37A2,18435,1602,1.13 [1.02-1.26],0.024419951785394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,18419,1587,1.10 [1.00-1.21],0.0467899578783009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,20914,1833,0.62 [0.56-0.69],3.5960085167693725e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,18454,1594,0.73 [0.60-0.89],0.0014756518722906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSP1,Lymphocyte-specific protein 1,21282,1863,1.11 [1.01-1.23],0.0336022371394483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,21472,1876,1.16 [1.10-1.23],3.466161294525202e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,21556,1882,1.56 [1.37-1.77],9.991999131466046e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,20784,1814,1.29 [1.20-1.38],1.1119892717575404e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,21148,1850,1.44 [1.25-1.66],3.9003328525104406e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LUZP2,Leucine zipper protein 2,18419,1587,0.89 [0.79-1.00],0.0492704914825425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY6D,Lymphocyte antigen 6D,21149,1851,1.17 [1.06-1.31],0.0031403185173514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,21040,1833,1.24 [1.08-1.42],0.002477957385142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,21104,1848,1.42 [1.29-1.58],6.343624185041724e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPLA2,Acyl-protein thioesterase 2,17877,1545,1.05 [1.00-1.09],0.0376341074610019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,21037,1843,1.18 [1.10-1.26],2.2758831193575914e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC4,Apical endosomal glycoprotein,18419,1587,1.25 [1.16-1.35],6.06075828855354e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",17992,1559,1.46 [1.21-1.76],8.483846565857145e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN2B2,Epididymis-specific alpha-mannosidase,18494,1603,1.11 [1.03-1.21],0.0078714873009595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANF,Mesencephalic astrocyte-derived neurotrophic factor,21367,1868,1.03 [1.00-1.07],0.048308269316694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC1,MANSC domain-containing protein 1,21352,1860,1.31 [1.14-1.51],0.0002317973812844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC4,MANSC domain-containing protein 4,17856,1551,1.09 [1.02-1.17],0.010887979611367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2,Microtubule-associated protein 2,18446,1599,1.13 [1.03-1.25],0.0113916279941834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK9,Mitogen-activated protein kinase 9,21282,1863,1.11 [1.01-1.22],0.0261291576065031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPRE3,Microtubule-associated protein RP/EB family member 3,17841,1543,0.92 [0.88-0.97],0.0011797737289944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARCO,Macrophage receptor MARCO,21289,1860,1.46 [1.24-1.72],3.797702168093383e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,21292,1863,1.64 [1.43-1.88],1.2695377872486474e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN3,Matrilin-3,21064,1844,1.21 [1.07-1.37],0.0031912671323311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAVS,Mitochondrial antiviral-signaling protein,20784,1814,1.07 [1.03-1.12],0.0020987952753604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MBL2,Mannose-binding protein C,18265,1595,1.07 [1.02-1.12],0.0033422150878331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCAM,Cell surface glycoprotein MUC18,21393,1864,0.86 [0.76-0.98],0.0230253550243696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEMP1,Mast cell-expressed membrane protein 1,17944,1562,1.08 [1.02-1.13],0.0077339168458418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,21178,1848,1.14 [1.05-1.25],0.0030651590428381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,21287,1853,1.36 [1.26-1.47],2.3891713348588206e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",17992,1559,1.08 [1.02-1.13],0.0053314322367003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,21480,1875,1.79 [1.45-2.22],9.420876321889284e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MENT,Protein MENT,18077,1558,0.77 [0.62-0.95],0.0144402716714856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,21289,1860,0.90 [0.87-0.94],8.645546968217975e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,21262,1860,0.66 [0.56-0.78],1.0842310435795285e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MERTK,Tyrosine-protein kinase Mer,21543,1879,1.20 [1.01-1.42],0.0365200616578498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MET,Hepatocyte growth factor receptor,21345,1859,0.63 [0.51-0.78],2.024039863655821e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",21282,1863,1.06 [1.01-1.11],0.0157146377484556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,21302,1865,1.26 [1.15-1.37],1.705323593686887e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MILR1,Allergin-1,20914,1833,1.13 [1.04-1.22],0.0023847876354728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLN,Promotilin,21282,1863,1.09 [1.04-1.14],0.0004859118471518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,21186,1853,1.23 [1.17-1.29],3.0662300124499224e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP1,Interstitial collagenase,20586,1806,1.08 [1.03-1.14],0.0011478714574986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,21222,1859,1.24 [1.16-1.33],1.5538684706565549e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,21324,1859,1.53 [1.43-1.64],6.418627110728406e-36
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP13,Collagenase 3,20838,1837,1.16 [1.01-1.32],0.0329464333163056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP15,Matrix metalloproteinase-15,18494,1603,1.09 [1.00-1.19],0.0497153729395972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP3,Stromelysin-1,21302,1865,1.12 [1.03-1.21],0.00682820927013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,20877,1830,1.40 [1.29-1.53],3.5581309509312067e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,21450,1874,1.21 [1.16-1.28],1.2597108915179766e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,21274,1865,1.29 [1.21-1.38],5.338702752651027e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNDA,Myeloid cell nuclear differentiation antigen,21257,1856,1.06 [1.02-1.10],0.0031322313343865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPO,Myeloperoxidase,21302,1865,1.19 [1.09-1.29],4.917673089043451e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,18509,1603,2.04 [1.74-2.40],2.7455444867576497e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,21151,1853,1.30 [1.23-1.36],8.514610435556264e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSMB,Beta-microseminoprotein,21267,1856,1.16 [1.09-1.23],8.1095768889848e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,21484,1876,1.37 [1.26-1.49],1.3481508425907717e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MST1,Hepatocyte growth factor-like protein,18245,1585,1.19 [1.09-1.30],8.773249959981384e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,20906,1832,0.81 [0.75-0.87],6.73180557167171e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,18165,1571,1.07 [1.03-1.12],0.0009624618575337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS2,Protein MTSS 2,18419,1587,1.06 [1.01-1.11],0.0191777345021954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,18165,1571,1.19 [1.10-1.28],1.292270110466607e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC13,Mucin-13,20838,1837,1.17 [1.08-1.27],5.595226936357331e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,20914,1833,1.22 [1.17-1.28],1.6185437238512374e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,18077,1558,0.77 [0.66-0.91],0.0021471953283661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,18454,1594,1.08 [1.01-1.16],0.0230078545230018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYDGF,Myeloid-derived growth factor,18494,1603,1.05 [1.01-1.11],0.0252241944536353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",17856,1551,0.80 [0.70-0.92],0.0016110172713056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL6B,Myosin light chain 6B,18001,1566,0.90 [0.84-0.96],0.0007404351886361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYO9B,Unconventional myosin-IXb,20914,1833,1.07 [1.01-1.14],0.0292834747260887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM3,Myomesin-3,18077,1558,0.93 [0.88-0.97],0.0029083738170043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,21323,1866,1.45 [1.35-1.55],3.4639219762875165e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NACC1,Nucleus accumbens-associated protein 1,18419,1587,1.09 [1.01-1.19],0.030571978196183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAPRT,Nicotinate phosphoribosyltransferase,18446,1599,0.83 [0.71-0.97],0.016962875475553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,21352,1860,1.32 [1.13-1.53],0.0003394692431242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBN,Nibrin,20914,1833,1.08 [1.01-1.15],0.0235821141732611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM1,Neural cell adhesion molecule 1,21393,1864,0.82 [0.73-0.93],0.0020200306410524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,21484,1876,0.75 [0.67-0.83],4.3106229687015406e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCF2,Neutrophil cytosol factor 2,21238,1861,1.07 [1.03-1.12],0.0016911706835993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",20784,1814,1.06 [1.01-1.11],0.0195240360596665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,21260,1858,1.59 [1.40-1.82],4.132424804404975e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN4,Nectin-4,21352,1860,1.28 [1.13-1.45],0.0001122428192343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,20779,1831,1.34 [1.23-1.46],2.0108664213945448e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,21352,1860,0.85 [0.77-0.93],0.0006036193475577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,21543,1879,1.47 [1.28-1.68],2.668367367389659e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFAT5,Nuclear factor of activated T-cells 5,17944,1562,1.07 [1.01-1.13],0.0269266510591001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",20914,1833,1.17 [1.10-1.24],2.0170898029411622e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,17655,1527,1.89 [1.61-2.21],2.041080747792106e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID1,Nidogen-1,21325,1860,1.16 [1.04-1.29],0.0091992339108581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME3,Nucleoside diphosphate kinase 3,21292,1863,1.53 [1.29-1.80],6.828243022807718e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMI,N-myc-interactor,18343,1580,1.09 [1.02-1.16],0.0113925395853277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOMO1,Nodal modulator 1,21302,1865,1.59 [1.33-1.90],3.3093487315253465e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",20838,1837,1.13 [1.05-1.22],0.0014994495005321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,21556,1882,0.72 [0.56-0.94],0.013351732537347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,18187,1579,1.76 [1.54-2.02],4.935623626295001e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,21289,1860,1.45 [1.28-1.64],2.443655913602968e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPL,N-acetylneuraminate lyase,18494,1603,1.27 [1.15-1.40],1.712569578677123e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,20906,1832,1.10 [1.07-1.14],4.647539006315003e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPR1,Atrial natriuretic peptide receptor 1,17856,1551,0.82 [0.71-0.96],0.0158945623071031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,21302,1865,1.45 [1.34-1.58],3.992086381424198e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX2,Neuronal pentraxin-2,18498,1605,1.31 [1.14-1.50],0.0001636927334948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTXR,Neuronal pentraxin receptor,21289,1860,0.87 [0.77-0.98],0.0274517984037538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP1,Neuropilin-1,21427,1865,1.24 [1.06-1.44],0.0063584042855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,18446,1599,1.66 [1.44-1.92],4.10764421252775e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C3A,Cytosolic 5'-nucleotidase 3A,21246,1860,0.95 [0.91-1.00],0.0473139278190099
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5E,5'-nucleotidase,21352,1860,1.28 [1.18-1.38],1.722656224306173e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF3,Neurotrophin-3,21282,1863,1.13 [1.00-1.26],0.0436858661092633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,21289,1860,0.85 [0.72-1.00],0.049052810741376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,21484,1876,0.68 [0.57-0.83],8.605443737441688e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,21289,1860,1.19 [1.14-1.23],3.1075013724525653e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUCB2,Nucleobindin-2,21439,1873,1.21 [1.09-1.35],0.0002909184812839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,18403,1599,1.08 [1.02-1.14],0.0047092354372267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],21186,1853,0.90 [0.84-0.97],0.0067397727815998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,21302,1865,1.15 [1.06-1.25],0.0007185714841099
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OBP2B,Odorant-binding protein 2b,21032,1841,0.92 [0.85-0.99],0.0189204615243442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,18454,1594,1.96 [1.77-2.16],1.886753268996058e-38
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGN,Mimecan,21302,1865,1.18 [1.07-1.30],0.001213745506499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLFM4,Olfactomedin-4,17412,1496,1.08 [1.04-1.12],0.000251811822634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,21076,1843,1.17 [1.11-1.24],2.027614484291561e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMD,Osteomodulin,21367,1868,0.74 [0.68-0.82],3.257395428872174e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,21186,1853,0.84 [0.79-0.89],7.977572354691066e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,18443,1605,2.29 [1.83-2.87],5.264925230083235e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,21292,1863,1.68 [1.49-1.89],6.066580703839952e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,21175,1854,1.28 [1.21-1.35],1.9044282184730048e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,21427,1865,2.30 [1.86-2.84],1.3581697692886443e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD7B,OTU domain-containing protein 7B,18454,1594,1.10 [1.02-1.18],0.0106545173545821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,21484,1876,1.06 [1.03-1.09],4.171706583941616e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",P4HB,Protein disulfide-isomerase,21193,1845,1.21 [1.09-1.34],0.0002251140026509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,18454,1594,0.94 [0.89-0.99],0.0301350514658743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,20906,1832,1.09 [1.02-1.17],0.0140132678349881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,18446,1599,1.84 [1.64-2.07],1.336713104404372e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,21469,1872,1.17 [1.01-1.36],0.042204065211508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARP1,Poly [ADP-ribose] polymerase 1,21282,1863,1.08 [1.02-1.15],0.0091590094487274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,18042,1555,1.19 [1.09-1.31],0.0001985402261879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH17,Protocadherin-17,21289,1860,0.87 [0.78-0.98],0.0232372268220934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH9,Protocadherin-9,18435,1602,0.82 [0.72-0.93],0.0023322986309619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDHB15,Protocadherin beta-15,18419,1587,0.85 [0.75-0.97],0.0153224558314802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,21556,1882,1.33 [1.20-1.47],4.7183470755038774e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD5,Programmed cell death protein 5,21484,1876,1.12 [1.04-1.20],0.0015919212599016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFA,Platelet-derived growth factor subunit A,21556,1882,1.07 [1.01-1.13],0.018302057432903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFB,Platelet-derived growth factor subunit B,21367,1868,1.09 [1.04-1.14],0.0005803565609855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,21289,1860,1.16 [1.00-1.35],0.0471024661996896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA3,Protein disulfide-isomerase A3,18077,1558,1.52 [1.24-1.85],4.885681984537104e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA5,Protein disulfide-isomerase A5,17841,1543,1.09 [1.00-1.18],0.0482533581879868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZD2,PDZ domain-containing protein 2,17856,1551,1.13 [1.05-1.23],0.0022584590772366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,17944,1562,1.42 [1.29-1.56],8.461910679322901e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEBP1,Phosphatidylethanolamine-binding protein 1,21302,1865,1.08 [1.01-1.16],0.035507343273165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECAM1,Platelet endothelial cell adhesion molecule,21302,1865,1.16 [1.02-1.33],0.0253319585011086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PENK,Proenkephalin-A,18077,1558,1.20 [1.02-1.42],0.027781162876024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEPD,Xaa-Pro dipeptidase,18509,1603,1.24 [1.04-1.48],0.0190998948400686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PF4,Platelet factor 4,18365,1602,1.07 [1.02-1.13],0.0043406138348167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,18509,1603,1.18 [1.10-1.27],1.7315069672683252e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,21543,1879,1.58 [1.41-1.78],9.558096568824068e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,21451,1873,1.27 [1.17-1.39],7.650341553619883e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,18289,1596,1.41 [1.19-1.67],5.676259220082102e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,18435,1602,1.17 [1.06-1.28],0.0009099505115367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,21104,1848,1.28 [1.10-1.48],0.0011681014231352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI16,Peptidase inhibitor 16,18509,1603,0.78 [0.64-0.96],0.0165475143246234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,21012,1833,1.20 [1.12-1.29],3.295036056183724e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,21029,1849,2.39 [2.16-2.63],1.942604196875392e-68
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,21282,1863,1.10 [1.03-1.17],0.0039104066418754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,21302,1865,1.50 [1.30-1.73],1.9931679671873743e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,21302,1865,1.44 [1.30-1.59],6.473894473541847e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,21289,1860,1.24 [1.15-1.33],2.590868721402628e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD1,Polycystin-1,18494,1603,1.24 [1.03-1.49],0.0220347486601721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD2,Polycystin-2,17856,1551,1.13 [1.04-1.23],0.0029006307478517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKN3,Serine/threonine-protein kinase N3,18165,1571,1.08 [1.01-1.14],0.0149247367297004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,21352,1860,2.26 [1.98-2.58],6.2969809317896495e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,21526,1880,0.90 [0.82-0.99],0.0226449003959269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",21264,1857,1.21 [1.13-1.30],5.9183519028222553e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,21480,1875,1.36 [1.25-1.47],2.245694836987331e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAU,Urokinase-type plasminogen activator,21302,1865,1.34 [1.16-1.56],8.133354304403274e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,21121,1852,2.69 [2.34-3.09],1.0549538089711908e-44
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLG,Plasminogen,18063,1579,1.96 [1.56-2.48],1.2079511797609132e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN1,Perilipin-1,20838,1837,1.15 [1.02-1.29],0.0179501715572757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN3,Perilipin-3,21289,1860,1.13 [1.03-1.25],0.0088224463360151
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLSCR3,Phospholipid scramblase 3,18404,1594,1.09 [1.01-1.18],0.0351964014317851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC1,Plexin domain-containing protein 1,20784,1814,0.76 [0.65-0.88],0.0004244722887479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB2,Plexin-B2,21444,1871,1.49 [1.27-1.76],1.8665351909555413e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMS1,PMS1 protein homolog 1,18001,1566,1.11 [1.01-1.22],0.0292962256811629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POF1B,Protein POF1B,17944,1562,1.16 [1.05-1.27],0.0031167466831633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",21186,1853,1.28 [1.16-1.40],2.6535813693109626e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,18509,1603,0.75 [0.64-0.87],0.0002151745733462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,20906,1832,1.31 [1.16-1.47],6.253233918747867e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POSTN,Periostin,18498,1605,0.85 [0.75-0.97],0.0118587658301984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPBP,Platelet basic protein,18367,1604,1.09 [1.03-1.15],0.0042202310472913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPCDC,Phosphopantothenoylcysteine decarboxylase,21484,1876,1.12 [1.02-1.22],0.0124182547742527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPL,Periplakin,17944,1562,1.41 [1.21-1.63],6.387507661826619e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,18454,1594,1.27 [1.14-1.41],1.4987243681663809e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPY,Pancreatic prohormone,21230,1848,1.05 [1.01-1.09],0.0172330109202688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PQBP1,Polyglutamine-binding protein 1,20784,1814,1.11 [1.05-1.19],0.0008861010192317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,18498,1605,1.59 [1.39-1.81],2.418197914492609e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,21425,1869,1.57 [1.38-1.78],4.380080219981997e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",20914,1833,1.07 [1.01-1.14],0.0161616493648379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX6,Peroxiredoxin-6,21472,1876,0.89 [0.83-0.95],0.000460152628084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PREB,Prolactin regulatory element-binding protein,20914,1833,1.32 [1.15-1.51],5.429516855128715e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG2,Bone marrow proteoglycan,18498,1605,1.17 [1.07-1.28],0.0008982644953534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,20784,1814,1.07 [1.01-1.14],0.0302791172552564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROC,Vitamin K-dependent protein C,21360,1861,0.83 [0.71-0.98],0.0322630983687405
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROS1,Vitamin K-dependent protein S,18511,1612,1.24 [1.03-1.51],0.0271170574633964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS2,Trypsin-2,21393,1864,1.32 [1.24-1.40],1.6156031586843405e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS22,Brain-specific serine protease 4,17944,1562,1.31 [1.18-1.46],8.160083383960934e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS27,Serine protease 27,21214,1853,1.13 [1.02-1.25],0.0199688319384703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,21188,1857,1.96 [1.79-2.15],6.727017956731066e-47
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTN3,Myeloblastin,20770,1811,1.15 [1.06-1.23],0.0002612740101745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,18332,1593,1.71 [1.45-2.00],5.0258740813664946e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,21104,1848,1.07 [1.03-1.11],0.0005949696437135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSIP1,PC4 and SFRS1-interacting protein,21282,1863,1.06 [1.00-1.12],0.0358428355737745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMC3,26S proteasome regulatory subunit 6A,17841,1543,0.76 [0.64-0.92],0.0037097392607613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSPN,Persephin,21282,1863,1.08 [1.03-1.14],0.0011892462987534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSRC1,Proline/serine-rich coiled-coil protein 1,20784,1814,1.09 [1.02-1.17],0.0110705862025468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,21144,1845,1.18 [1.03-1.36],0.0180783137816745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGR1,Prostaglandin reductase 1,18494,1603,1.08 [1.02-1.14],0.0049935202477276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,20838,1837,1.24 [1.11-1.40],0.0002769574577576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,20906,1832,1.16 [1.07-1.26],0.0005016936228252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTP4A3,Protein tyrosine phosphatase type IVA 3,17944,1562,1.14 [1.04-1.25],0.0062163648846978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,21104,1848,1.07 [1.02-1.13],0.0062926132365338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,18494,1603,1.57 [1.37-1.81],1.9668072911665582e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,18435,1602,0.86 [0.78-0.95],0.0025102280797145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,18435,1602,1.30 [1.04-1.61],0.0187062391798945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,21035,1839,1.19 [1.05-1.35],0.0054867673280662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,21556,1882,0.81 [0.69-0.95],0.0116215315943229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,20738,1830,1.09 [1.01-1.18],0.0204498941064508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTX3,Pentraxin-related protein PTX3,21282,1863,1.22 [1.11-1.33],1.3382887952150667e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,21484,1876,1.60 [1.44-1.76],4.467113503961564e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYY,Peptide YY,17856,1551,1.09 [1.04-1.14],0.0002516765210645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QDPR,Dihydropteridine reductase,21179,1851,1.10 [1.00-1.21],0.0478728043668741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,21307,1858,1.27 [1.09-1.48],0.0017817369977474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QSOX1,Sulfhydryl oxidase 1,18147,1576,1.28 [1.18-1.39],4.731371734380714e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAP1A,Ras-related protein Rap-1A,17944,1562,0.92 [0.85-1.00],0.0403328535660365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,21427,1865,1.32 [1.22-1.43],1.1459103938782258e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASSF2,Ras association domain-containing protein 2,20784,1814,1.12 [1.06-1.18],0.0001255608116577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,18454,1594,1.44 [1.29-1.61],5.400093291860273e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,21186,1853,1.17 [1.11-1.23],4.947459287813322e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,21186,1853,1.32 [1.23-1.42],3.955197199440054e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP7,Retinoid-binding protein 7,18435,1602,1.16 [1.09-1.24],5.683984245114418e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS2,RNA-binding protein with multiple splicing 2,17992,1559,1.05 [1.00-1.10],0.0348628619451439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCC1,Regulator of chromosome condensation,18419,1587,1.16 [1.06-1.26],0.0011872483552709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,21181,1846,1.30 [1.21-1.41],3.0412288973010814e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,21556,1882,1.24 [1.16-1.32],5.103191731555311e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,21556,1882,1.20 [1.13-1.27],4.665485776730256e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3G,Regenerating islet-derived protein 3-gamma,18419,1587,1.16 [1.03-1.30],0.0154190668691152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,21292,1863,1.40 [1.30-1.52],8.385932744007088e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,21302,1865,1.54 [1.35-1.77],5.002991633911197e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,21289,1860,1.17 [1.11-1.23],1.6119847599191522e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,21186,1853,0.81 [0.72-0.90],0.0001747154948255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RETN,Resistin,21254,1859,1.16 [1.06-1.27],0.0018384670767582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMA,Repulsive guidance molecule A,21484,1876,0.74 [0.65-0.84],4.262568422701298e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,18077,1558,1.16 [1.06-1.27],0.0015738184305159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN2,Prorelaxin H2,18047,1554,0.89 [0.80-0.98],0.02337516212578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,18509,1603,1.82 [1.50-2.20],7.287844765775495e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,17924,1555,1.56 [1.31-1.86],6.825904217752372e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,18389,1595,1.48 [1.28-1.71],1.0007096206465525e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,21461,1872,1.50 [1.29-1.74],7.065390320113804e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,17992,1559,1.73 [1.48-2.01],1.876268347551792e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF31,E3 ubiquitin-protein ligase RNF31,17944,1562,0.85 [0.73-0.99],0.0337756722095396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF43,E3 ubiquitin-protein ligase RNF43,18165,1571,1.13 [1.05-1.21],0.0006016184274703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO1,Roundabout homolog 1,21292,1863,1.32 [1.11-1.57],0.00164539532788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RP2,Protein XRP2,21186,1853,1.10 [1.00-1.20],0.0443040820961895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPL14,60S ribosomal protein L14,17992,1559,1.16 [1.04-1.31],0.0107733968588397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,20784,1814,1.22 [1.13-1.32],2.746498179452663e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,21104,1848,1.55 [1.37-1.74],4.406138764404712e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO3,R-spondin-3,21472,1876,1.29 [1.11-1.49],0.0006849275128221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A11,Protein S100-A11,21126,1846,1.19 [1.10-1.28],9.662064883635174e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A12,Protein S100-A12,20973,1838,1.09 [1.03-1.15],0.0024426837294333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100G,Protein S100-G,18454,1594,1.09 [1.00-1.19],0.0466807728166267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAA4,Serum amyloid A-4 protein,18511,1612,1.23 [1.06-1.43],0.0060562041171272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SART1,U4/U6.U5 tri-snRNP-associated protein 1,17856,1551,1.19 [1.08-1.31],0.0005492357375958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCAMP3,Secretory carrier-associated membrane protein 3,21186,1853,1.05 [1.00-1.10],0.044195871415455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARA5,Scavenger receptor class A member 5,21484,1876,1.25 [1.08-1.43],0.0019649893964815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB1,Scavenger receptor class B member 1,20838,1837,1.16 [1.07-1.25],0.0001550087775778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,20690,1804,1.60 [1.40-1.82],1.2901904946093113e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF1,Scavenger receptor class F member 1,21556,1882,1.16 [1.05-1.27],0.0028760175743459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF2,Scavenger receptor class F member 2,21484,1876,1.35 [1.16-1.57],9.05955916905159e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG2,Secretogranin-2,21385,1868,1.15 [1.01-1.30],0.0302971359643401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,21297,1864,0.81 [0.76-0.86],8.896476802290272e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,18077,1558,1.81 [1.53-2.15],1.1598180640585199e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,21336,1865,1.17 [1.12-1.22],1.7565966855557925e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCIN,Adseverin,17877,1545,0.92 [0.86-0.99],0.0316765097596233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,21418,1871,1.37 [1.26-1.49],6.753515063294168e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCP2,Non-specific lipid-transfer protein,20784,1814,1.06 [1.00-1.12],0.0435694602941832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,17930,1557,1.19 [1.08-1.30],0.0003047462997006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRG1,Scrapie-responsive protein 1,18494,1603,1.26 [1.06-1.48],0.0075127608363278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRIB,Protein scribble homolog,17992,1559,1.07 [1.01-1.12],0.0149226545817909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC1,Syndecan-1,21289,1860,1.22 [1.10-1.35],0.000170000996101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDHB,Succinate dehydrogenase,18435,1602,1.15 [1.07-1.23],0.0001046545620492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEL1L,Protein sel-1 homolog 1,17992,1559,1.33 [1.14-1.56],0.0004017114019085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,21556,1882,1.36 [1.25-1.48],1.964722415889547e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,18511,1612,0.54 [0.43-0.67],2.5276546795046948e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN3,Neuronal-specific septin-3,18454,1594,1.14 [1.07-1.22],3.212106336188818e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,18412,1594,1.59 [1.40-1.80],5.968414602134719e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA1,Alpha-1-antitrypsin,18177,1582,3.10 [2.06-4.66],5.951301126898096e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA11,Serpin A11,21556,1882,1.25 [1.13-1.38],1.189666685141015e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,18459,1607,2.62 [2.04-3.37],4.0958769402215485e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA6,Corticosteroid-binding globulin,18511,1612,2.00 [1.48-2.69],5.122582244602673e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA9,Serpin A9,21099,1848,1.11 [1.05-1.17],8.189097319993382e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,21543,1879,1.12 [1.06-1.19],4.4635349792636414e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINC1,Antithrombin-III,18483,1611,0.71 [0.51-0.98],0.0364650510650237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,18483,1611,1.69 [1.43-2.00],7.259146580527672e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,21556,1882,1.17 [1.10-1.25],3.868761528498425e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE2,Glia-derived nexin,18494,1603,1.09 [1.02-1.17],0.0169996831509158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF2,Alpha-2-antiplasmin,18170,1580,0.51 [0.35-0.74],0.0003172071024252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,18483,1611,2.59 [2.00-3.36],6.578593686675116e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINH1,Serpin H1,18165,1571,1.05 [1.01-1.09],0.0066790991953878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SETMAR,Histone-lysine N-methyltransferase SETMAR,21027,1843,1.16 [1.02-1.32],0.0200589949179831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L2,Seizure 6-like protein 2,21186,1853,1.21 [1.01-1.44],0.0384370305341457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,21024,1837,1.24 [1.13-1.36],3.406159523891633e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP4,Secreted frizzled-related protein 4,18077,1558,0.77 [0.68-0.88],6.729429325454795e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,20784,1814,1.19 [1.12-1.27],1.7317785034252263e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,20784,1814,1.30 [1.23-1.38],4.157160826761378e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,21289,1860,1.12 [1.05-1.19],0.0002960162413431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,18201,1572,1.19 [1.10-1.29],1.2909642570960772e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHBG,Sex hormone-binding globulin,18509,1603,1.12 [1.01-1.25],0.0372181259717956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,18498,1605,1.90 [1.59-2.27],2.560675690885647e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHMT1,"Serine hydroxymethyltransferase, cytosolic",21336,1865,1.05 [1.00-1.10],0.0420221543592528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,21315,1859,1.24 [1.14-1.35],8.782816690675777e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,21367,1868,1.41 [1.28-1.55],1.4731789674716045e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,21282,1863,1.37 [1.21-1.54],2.63229348978255e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,21302,1865,1.05 [1.01-1.09],0.0226552970686362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,21472,1876,1.15 [1.02-1.29],0.0204472517521531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,21289,1860,1.98 [1.71-2.29],1.6921629620228718e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,17992,1559,1.32 [1.18-1.47],9.428619382016736e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,21442,1872,1.26 [1.10-1.44],0.0008245786007906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIL1,Nucleotide exchange factor SIL1,17992,1559,1.15 [1.02-1.31],0.0277489553940343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,21347,1863,1.10 [1.02-1.18],0.0139313106605767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,21222,1856,1.19 [1.09-1.29],9.231784643708748e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,20914,1833,1.14 [1.06-1.22],0.0002324531863354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,21075,1846,1.07 [1.01-1.13],0.012837937534805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,20914,1833,1.18 [1.10-1.26],5.609704479220261e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF6,SLAM family member 6,20784,1814,1.16 [1.04-1.30],0.0082017775450656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF7,SLAM family member 7,21282,1863,1.21 [1.13-1.28],7.047319169164821e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,20784,1814,1.23 [1.13-1.33],1.050502594916358e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC16A1,Monocarboxylate transporter 1,20838,1837,1.12 [1.05-1.19],0.0007303694351482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC27A4,Long-chain fatty acid transport protein 4,20838,1837,1.10 [1.03-1.17],0.0038307142751298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A14,Zinc transporter ZIP14,20838,1837,1.30 [1.16-1.46],1.2451718700416071e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A5,Zinc transporter ZIP5,21282,1863,1.17 [1.08-1.26],8.04450668678147e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,18435,1602,1.11 [1.01-1.22],0.0251132009284116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",17841,1543,1.11 [1.03-1.20],0.0072186668221491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIT2,Slit homolog 2 protein,20838,1837,1.12 [1.04-1.22],0.004779576551489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,17944,1562,0.65 [0.56-0.76],1.1470407464315564e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,21472,1876,0.73 [0.66-0.81],3.88758871236522e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLMAP,Sarcolemmal membrane-associated protein,18435,1602,1.06 [1.00-1.12],0.0407643480223532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD5,Mothers against decapentaplegic homolog 5,21186,1853,1.50 [1.21-1.87],0.0002357285522061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,18435,1602,1.15 [1.08-1.22],9.72527162102273e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,21472,1876,1.15 [1.03-1.30],0.0160441216115098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,21367,1868,1.13 [1.01-1.26],0.0260325371834286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,21381,1862,1.45 [1.35-1.55],1.0487121896019071e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,21327,1864,1.22 [1.15-1.30],6.093948448714408e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMTN,Smoothelin,18409,1596,1.12 [1.06-1.18],1.6850628311044665e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNCG,Gamma-synuclein,21104,1848,1.10 [1.03-1.17],0.0031087388132305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',18446,1599,1.18 [1.09-1.28],4.947912865673035e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",21302,1865,1.47 [1.33-1.63],1.354434661920746e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,20784,1814,1.23 [1.10-1.37],0.0002725212803414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORT1,Sortilin,21260,1858,1.27 [1.14-1.41],1.2676275177756334e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOX2,Transcription factor SOX-2,18415,1592,1.28 [1.03-1.59],0.0258705664876703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARC,SPARC,21352,1860,1.11 [1.05-1.18],0.0003779076402361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPART,Spartin,18077,1558,1.06 [1.00-1.13],0.049537258046541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,21302,1865,1.56 [1.42-1.72],5.190459504886741e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,18077,1558,1.32 [1.16-1.51],4.04648600536248e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,21282,1863,1.14 [1.07-1.21],6.353442194662002e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,21472,1876,1.16 [1.07-1.26],0.0002332866870697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,21221,1856,1.84 [1.59-2.13],3.60667352080942e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,21367,1868,1.20 [1.08-1.33],0.000494541045546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,18435,1602,0.97 [0.94-1.00],0.0481049086958276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,21292,1863,1.73 [1.54-1.93],2.971721036479176e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,21186,1851,1.82 [1.61-2.05],1.0243012219333925e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPP1,Osteopontin,21527,1880,1.26 [1.15-1.37],1.826534502240293e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR3,Small proline-rich protein 3,18446,1599,1.13 [1.04-1.22],0.0028936832434135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRP14,Signal recognition particle 14 kDa protein,21186,1853,1.09 [1.02-1.16],0.0127970766429139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,18494,1603,1.17 [1.03-1.34],0.0173240682171397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,21260,1858,0.84 [0.81-0.87],7.94471309299198e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,21393,1864,1.22 [1.11-1.34],3.6611552056023e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",21556,1882,1.69 [1.49-1.91],6.712644133062566e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAB2,Stabilin-2,18498,1605,1.63 [1.38-1.93],8.439924528984384e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAT2,Signal transducer and activator of transcription 2,17944,1562,1.08 [1.02-1.15],0.0144544016131376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,21484,1876,1.26 [1.16-1.36],4.035641302572639e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STOML2,"Stomatin-like protein 2, mitochondrial",17841,1543,0.94 [0.89-1.00],0.0413285799554021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX4,Syntaxin-4,21186,1853,1.10 [1.03-1.18],0.002821557219936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX8,Syntaxin-8,21282,1863,1.15 [1.06-1.25],0.0006858954056522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,21282,1863,1.27 [1.20-1.34],1.4164958219169914e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,21484,1876,1.14 [1.05-1.23],0.0017999712512628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUOX,"Sulfite oxidase, mitochondrial",18454,1594,1.08 [1.00-1.17],0.0419805340242413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,21302,1865,1.65 [1.47-1.85],2.5135439703454328e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD5,Sushi domain-containing protein 5,17994,1552,0.74 [0.65-0.85],1.3486152213325671e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SWAP70,Switch-associated protein 70,18435,1602,1.15 [1.02-1.30],0.0229599950323654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYT1,Synaptotagmin-1,18446,1599,1.18 [1.04-1.34],0.0104862381063995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,18848,1635,1.30 [1.11-1.51],0.0008185460598615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,21186,1853,1.35 [1.21-1.51],7.568066378900482e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TALDO1,Transaldolase,18439,1602,1.14 [1.03-1.26],0.0094536354810435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAX1BP1,Tax1-binding protein 1,18446,1599,1.14 [1.06-1.23],0.0005961926834385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D5,TBC1 domain family member 5,21282,1863,1.06 [1.01-1.11],0.0288834025901007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN1,Transcobalamin-1,18153,1573,1.24 [1.08-1.43],0.0023555582001218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN2,Transcobalamin-2,21527,1880,1.45 [1.27-1.66],5.4533356516302074e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCOF1,Treacle protein,18494,1603,1.27 [1.13-1.44],9.44194521039537e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,18494,1603,1.63 [1.40-1.89],1.6395091541524268e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDO2,"Tryptophan 2,3-dioxygenase",18001,1566,1.16 [1.03-1.30],0.0119242537741206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEK,Angiopoietin-1 receptor,21352,1860,1.36 [1.13-1.63],0.001244192628552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TF,Serotransferrin,18511,1612,1.48 [1.18-1.86],0.0006460163934589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,21207,1860,1.23 [1.18-1.29],3.576823880841489e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,21336,1865,1.50 [1.41-1.59],3.26981139871573e-38
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,21286,1847,1.46 [1.33-1.60],5.160589228283567e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI,Tissue factor pathway inhibitor,21250,1853,1.35 [1.19-1.53],3.726061349929068e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,21294,1853,1.27 [1.18-1.37],4.643913149944e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TG,Thyroglobulin,18419,1587,0.95 [0.90-1.00],0.0320047880471403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,21282,1863,1.41 [1.31-1.51],2.474243860196751e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,21507,1876,1.36 [1.23-1.50],2.080959967188673e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB2,Transforming growth factor beta-2 proprotein,18419,1587,1.11 [1.02-1.22],0.021951767903969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,21182,1846,1.45 [1.24-1.70],2.753678780751186e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR1,TGF-beta receptor type-1,17944,1562,1.37 [1.08-1.74],0.0098363227927809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,21352,1860,1.35 [1.20-1.52],6.380882266960723e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,21302,1865,1.68 [1.51-1.87],1.1433014270253737e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THOP1,Thimet oligopeptidase,21189,1855,1.39 [1.23-1.57],2.255437928890863e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THY1,Thy-1 membrane glycoprotein,21484,1876,1.17 [1.01-1.35],0.0348315182699075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,21556,1882,1.14 [1.03-1.27],0.0109074737028723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",20809,1835,1.12 [1.03-1.22],0.0089995404106705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,18165,1571,1.21 [1.07-1.37],0.0022664991134241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,21393,1864,1.18 [1.07-1.29],0.0005728723655837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,21081,1833,1.96 [1.70-2.26],3.1740637026039764e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,21367,1868,1.05 [1.02-1.08],0.0024490244472174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,21302,1865,1.75 [1.60-1.91],4.2331322628680515e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR1,Toll-like receptor 1,17944,1562,1.22 [1.01-1.49],0.0430656859922658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR2,Toll-like receptor 2,18165,1571,1.32 [1.07-1.63],0.009774689637092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,18412,1594,1.39 [1.23-1.57],1.579110135152627e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS5,Transmembrane protease serine 5,21002,1837,0.87 [0.78-0.96],0.0061761701520193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMSB10,Thymosin beta-10,21302,1865,1.11 [1.06-1.17],8.410459932828322e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNC,Tenascin,21393,1864,1.25 [1.15-1.36],4.180220706058246e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNF,Tumor necrosis factor,20880,1828,1.26 [1.12-1.40],5.240357787964952e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,18435,1602,1.14 [1.05-1.24],0.0010928857879334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,21104,1848,1.83 [1.62-2.06],1.3470983204878608e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,21104,1848,1.70 [1.66-1.75],0.0
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,21361,1863,1.18 [1.09-1.29],0.0001115175825211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,21543,1879,1.30 [1.17-1.44],5.197739089332935e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,21262,1860,1.93 [1.72-2.16],7.575504619659171e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,21352,1860,1.66 [1.48-1.85],1.5800169478525725e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,21292,1863,1.28 [1.16-1.43],3.386681838965541e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,20914,1833,0.88 [0.80-0.97],0.0086175973338399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,21292,1863,1.40 [1.23-1.60],3.993093861720141e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,18077,1558,1.17 [1.04-1.32],0.0077871022572616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,21472,1876,1.19 [1.05-1.35],0.0082245652624698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,21302,1865,1.78 [1.57-2.03],1.88126659514338e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,21302,1865,1.44 [1.31-1.59],5.04389880500512e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,21484,1876,1.35 [1.17-1.56],2.9594094423276898e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,21507,1876,1.18 [1.06-1.31],0.0033838259437699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,21104,1848,1.40 [1.31-1.49],2.6946268776999744e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,21484,1876,1.15 [1.05-1.26],0.0021614712014724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,21104,1848,1.27 [1.16-1.39],2.650801740418938e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,21543,1879,0.76 [0.65-0.89],0.0004847784725407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,21282,1863,0.81 [0.76-0.86],3.420385061620471e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,21543,1879,0.67 [0.58-0.77],2.5778532302242136e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,21367,1868,1.63 [1.41-1.88],5.2330831824955e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,21521,1879,1.88 [1.64-2.16],1.0983267168053396e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,21104,1848,1.10 [1.03-1.17],0.0060919991433987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNIP1,TNFAIP3-interacting protein 1,18446,1599,1.07 [1.01-1.13],0.014771884695867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNN,Tenascin-N,18498,1605,0.86 [0.77-0.96],0.0078047684975051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,21104,1848,0.67 [0.61-0.74],4.123554645436096e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,18494,1603,1.08 [1.02-1.15],0.0103447228127712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1,DNA topoisomerase 1,18435,1602,0.94 [0.90-0.98],0.0027988579864224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP2B,DNA topoisomerase 2-beta,17944,1562,1.06 [1.00-1.13],0.0402223332976369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53I3,Quinone oxidoreductase PIG3,17689,1528,1.10 [1.00-1.20],0.0392410864621728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,21124,1852,1.50 [1.40-1.61],4.687438749375709e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPR,Nucleoprotein TPR,17856,1551,1.10 [1.02-1.19],0.0180403580748548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREH,Trehalase,18498,1605,0.92 [0.86-0.98],0.0060817546186982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,21262,1860,1.47 [1.37-1.58],9.029777978915578e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,21472,1876,1.12 [1.05-1.20],0.000386514151193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSHB,Thyrotropin subunit beta,21289,1860,0.93 [0.87-0.98],0.0139848501100697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN7,Tetraspanin-7,17877,1545,0.88 [0.83-0.94],6.55606874113328e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN8,Tetraspanin-8,18435,1602,1.13 [1.08-1.19],1.2801624781272986e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTR,Transthyretin,18325,1596,0.75 [0.61-0.91],0.0031556063573938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,21352,1860,1.60 [1.38-1.86],2.874130623493106e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,21484,1876,1.11 [1.05-1.18],0.0003046331424462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNL1,Thioredoxin-like protein 1,17845,1543,0.93 [0.88-0.98],0.0033794055611399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",21302,1865,1.10 [1.01-1.20],0.0301668194163192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYMP,Thymidine phosphorylase,21159,1850,1.13 [1.07-1.21],5.821177532079018e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",17944,1562,1.11 [1.02-1.20],0.0106255604944069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,18494,1603,1.10 [1.02-1.19],0.0132164903617525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,21104,1848,1.37 [1.23-1.52],2.8019199337345704e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,21479,1874,0.82 [0.76-0.88],5.0490778235060266e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPB1,Beta-ureidopropionase,18494,1603,1.08 [1.03-1.13],0.0023750832737227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,18446,1599,1.26 [1.12-1.41],0.0001094064938969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UXS1,UDP-glucuronic acid decarboxylase 1,20784,1814,1.09 [1.01-1.19],0.0358971297750439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,20906,1832,1.29 [1.20-1.39],1.1318753353455425e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP8,Vesicle-associated membrane protein 8,17944,1562,1.06 [1.01-1.12],0.0263374414830367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASN,Vasorin,20970,1831,0.82 [0.70-0.96],0.0127550757244404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,21186,1853,0.77 [0.62-0.94],0.0126612431564081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAM1,Vascular cell adhesion protein 1,21360,1861,1.20 [1.03-1.39],0.0224275899192516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAN,Versican core protein,21484,1876,1.31 [1.15-1.49],5.589054371550472e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,21472,1872,1.21 [1.13-1.30],2.7731502468053886e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFB,Vascular endothelial growth factor B,17944,1562,1.32 [1.11-1.56],0.0016819843061925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFC,Vascular endothelial growth factor C,21352,1860,1.08 [1.01-1.16],0.0322226587164531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFD,Vascular endothelial growth factor D,21512,1876,1.26 [1.12-1.40],6.722625384685252e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIT,Vitrin,18494,1603,1.23 [1.08-1.40],0.0012844057989684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,21186,1853,1.08 [1.02-1.15],0.0122622059239022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN1,Pantetheinase,18509,1603,1.08 [1.02-1.16],0.016104336927108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,21186,1853,1.21 [1.11-1.32],2.0345590895490943e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,17856,1551,1.34 [1.18-1.53],1.2678580842244315e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,18419,1587,1.28 [1.19-1.37],3.6313826250368857e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,21273,1858,1.55 [1.40-1.71],5.794145320740927e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSNL1,Visinin-like protein 1,18446,1599,1.26 [1.14-1.39],6.701430506236496e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,20838,1837,1.12 [1.03-1.21],0.0067736087483794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,20906,1832,1.10 [1.02-1.17],0.0079954399763124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,18077,1558,1.10 [1.02-1.19],0.0142604084709079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,21448,1875,1.63 [1.50-1.78],3.287985869851629e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2,Brorin,21035,1842,1.24 [1.12-1.37],2.1674970608737903e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",21302,1865,1.30 [1.16-1.45],4.855530969319645e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASL,Neural Wiskott-Aldrich syndrome protein,17944,1562,0.88 [0.80-0.96],0.0066813584018471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WDR46,WD repeat-containing protein 46,18419,1587,1.15 [1.02-1.29],0.0243861753920903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,21428,1871,1.19 [1.12-1.27],3.806290206765087e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,20247,1746,1.93 [1.78-2.10],2.488928804817489e-53
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",21027,1843,0.64 [0.58-0.71],1.618368323592654e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WIF1,Wnt inhibitory factor 1,21472,1876,1.36 [1.21-1.52],1.5753661791989017e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WNT9A,Protein Wnt-9a,20914,1833,1.34 [1.16-1.55],9.526035795140074e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XCL1,Lymphotactin,21472,1876,1.13 [1.05-1.23],0.0014014251260866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XRCC4,DNA repair protein XRCC4,20838,1837,1.14 [1.01-1.28],0.0274855797362294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,18446,1599,1.73 [1.45-2.06],6.019736290344794e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,20906,1832,1.22 [1.12-1.33],3.6425977263754415e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZHX2,Zinc fingers and homeoboxes protein 2,18446,1599,1.19 [1.06-1.34],0.00402050483458
